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ABSTRACT

Introduction Arthropod-borne viruses (arboviruses)
are of notable public health importance worldwide,
owing to their potential to cause explosive outbreaks
and induce debilitating and potentially life-threatening
disease manifestations. This systematic review and meta-
analysis aims to assess the relationship between markers
of socioeconomic position (SEP) and infection due to
arboviruses with mosquito vectors.
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studies. Study findings were extracted and summarised, and
pooled estimates were obtained using random-effects meta-
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authors.
Results We identified 36 observational studies using data
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pertaining to 106 524 study participants in 23 geographic
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locations that empirically examined the relationship between
socioeconomic factors and infections caused by seven
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Rift Valley fever, Sindbis, West Nile and Zika viruses). While
results were varied, descriptive synthesis pointed to a higher
risk of arbovirus infection associated with markers of lower
SEP, including lower education, income poverty, low healthcare
coverage, poor housing materials, interrupted water supply,
marital status (married, divorced or widowed), non-white
ethnicities and migration status. Pooled crude estimates
indicated an increased risk of arboviral infection associated
with lower education (risk ratio, RR 1.5 95% CI 1.3 to 1.9);
I2=83.1%), interruption of water supply (RR 1.2; 95% CI 1.1 to
1.3; I2=0.0%) and having been married (RR 1.5 95% CI 1.1 to
2.1; I2=85.2%).
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WHAT IS ALREADY KNOWN?
⇒ Arboviruses with mosquito vectors are of nota-

ble global public health importance owing to their
potential to cause explosive outbreaks and induce
debilitating and potentially life-threatening disease
manifestations.
⇒ In regions with established arboviral circulation,
factors indicative of socioeconomic position, such
as increased population density, inadequate water
management and poor housing conditions, may exacerbate vector proliferation and elevate infection
risks.

WHAT ARE THE NEW FINDINGS?
⇒ Descriptive synthesis pointed to a higher risk of ar-

boviral infection associated with markers of lower
socioeconomic position, including lower education,
income poverty, low healthcare coverage, poor
housing materials, interruptions of water supply,
marital status (married, divorced or widowed) and
non-white ethnicity.
⇒ Pooled crude estimates from meta-analyses indicated an increased risk of arboviral infection associated
with having lower education, interruption of water
supply and having ever been married.

WHAT DO THE NEW FINDINGS IMPLY?
⇒ This review underscores the importance of evaluat-

ing the arbovirus-related impacts of social protection policies that aim to reduce the consequences
of poverty (eg, conditional cash transfer, housing
and public works programmes) alongside continuing research on more conventional vector control
interventions.

INTRODUCTION
Arthropod-
borne viruses (arboviruses) are
transmitted between vertebrate hosts by
haematophagous (blood-feeding) arthropod
vectors, including mosquitoes and ticks.1
Arboviruses with mosquito vectors, such as
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dengue virus (DENV) and chikungunya virus (CHIKV),
are of notable public health importance worldwide
owing to their potential to cause explosive outbreaks
and induce debilitating and potentially life-threatening
disease manifestations.2 In addition, congenital arboviral
infections, such as with Zika virus (ZIKV), may result in
severe congenital malformations with the potential to
incur lifelong health and social costs for affected individuals and their families.1–4
Infection due to arboviruses with mosquito vectors is
becoming increasingly prevalent. The burden of DENV
has grown dramatically in recent decades, with substantial impact on morbidity and mortality worldwide,
and ZIKV, CHIKV and Yellow Fever virus (YFV) have
re-emerged.5 Environmental factors, such as climate
change (eg, rising temperatures) and habitat modification (eg, deforestation) along with social factors, such as
increased international mobility, contribute to the global
spread of competent vectors and arboviruses.6 7 In regions
with established arboviral circulation, community-
level
factors, such as increased population density, inadequate
water management, and poor housing, may exacerbate
vector proliferation and elevate infection risks.8 This has
been reported by several ecological studies, which have
shown increased levels of arboviral infections in economically deprived areas at the population-level.9–11 Furthermore, a recent systematic review employing descriptive
synthesis reported a greater presence of Aedes mosquito
vectors and associated arboviral diseases in regions with
lower socioeconomic conditions in 50%–60% of evaluated studies.12 As described in the early social epidemiology literature, steep inverse associations between social
class and mortality from a wide range of diseases exist.13
To better understand individual- and household-level risk
factors for arboviral infections, we conducted a systematic
review and meta-analysis synthesising published evidence
on the relationship between markers of socioeconomic
position (SEP) and infection due to arboviruses with
mosquito vectors.

with individuals from any age group, and included peer-
reviewed observational case reports, case series or studies
that had a cross-sectional, case–control or cohort study
design. Studies assessing the association between SEP
and/or proxy measures of SEP (eg, individual social
class, living conditions, education, employment, household income, race/ethnicity and asset ownership) at
the individual-
level or household-
level and the occurrence of acute, recent or past arboviral infection, indicated by laboratory confirmation, were included. Laboratory confirmation of arbovirus infection was based on
the presence of viral RNA, antigen and/or serological
evidence (eg, IgM or IgG); the quality of assays used in
the individual studies was not appraised. Studies from
grey literature, using an ecological design, evaluating
the economic burden of arboviral infections, or only
describing the natural history of disease were excluded
(online supplemental material 2).

METHODS
Search strategy and eligibility criteria
The protocol for this systematic literature review was
registered in the International Prospective Register of
Systematic Reviews (PROSPERO) as CRD42019158572
and was conducted in line with the 2009 Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines.14 We searched for studies
measuring the association between SEP and arboviral
infection published between 1 January 1980 and 30
June 2020 in MEDLINE (PubMed), Embase (Ovid) and
LILACS (see online supplemental material 1), hypothesising that studies published more than 40 years prior
to this work would lack relevance to current research.
The search and full-text review were restricted to articles
published in English, Portuguese, Spanish and French.
Studies were eligible from any geographic location and
2

Data extraction and meta-analysis
Data on the author, year of publication, study period,
study type, source of population, data source, duration of
follow-up (if applicable), geographic location, age, sex,
individual-level and household-level socioeconomic characteristics, arbovirus infection type, comparison groups,
confounders, frequency (number and percentage) and
effect estimates (risk ratio (RR) or odds ratio (OR)) were
extracted from studies and consolidated. Data screening
was conducted in duplicate by four investigators (GMP,
LQ, JMP and NSC) and extraction in duplicate by two
investigators (GMP and AV). Discrepancies were resolved
by consensus. Two reviewers (GMP and LQ) evaluated
study quality by conducting a bias assessment using the
Newcastle-Ottawa scale (NOS) for individual-level studies
(NOS ranges from zero to nine). The NOS form for
cohort studies was also used to evaluate data quality for
cross-sectional studies; however, the maximum score is
limited to six as it was not possible to demonstrate absence
of infection at the start of these studies due to the lack of
follow-up (online supplemental table 1). Evaluation was
performed in duplicate, and discrepancies were resolved
by consensus.
When effect estimates were provided for an indicator
with comparable parameters in at least three cohort and/
or cross-sectional studies, pooled effect sizes and the 95%
CIs were calculated using random-effects meta-analyses.
Since studies were highly heterogeneous, a random-
effects model was preferred.15 Heterogeneity in RR estimates were assessed using I2 statistics and Cochran’s Q
test p values. Case–control studies were not included in
the meta-analyses since ORs with 95% CIs were calculated
from these study data and, given the high frequency of
infections in study populations, were considered to be not
directly comparable with cohort and/or cross-sectional
relative risk (RR) effect estimates. Further subgroup
analyses were conducted for each virus within each of the
meta-
analyses. Analyses were performed using STATA
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Figure 1 PRISMA flow chart illustrating selection of studies. PRISMA, Preferred Reporting Items for Systematic Reviews and
Meta-Analyses; SEP, socioeconomic position.

(V.14.0). A map indicating locations where studies were
based was created using Tableau software.
Patient and public involvement
The patients and the public were not involved in the
design, conduct or reporting of our research.
RESULTS
Our search generated 3928 published records. After
screening titles and abstracts, 110 manuscripts were
assessed for eligibility. Of these, 36 articles were deemed
eligible for inclusion in this systematic review (figure 1).
All studies included in this review were published
between 1995 and 2020, the majority of which were
published between 2015 and 2020 (n=28) and focused
on DENV (n=21), CHIKV (n=6), Japanese encephalitis (JEV) (n=1), Sindbis virus (SINV) (n=1), West Nile
virus (WNV) (n=1), ZIKV (n=1), DENV and JEV (n=2),
DENV, CHIKV and Rift Valley fever virus (RVFV) (n=1)
and flaviviruses in general with other arboviruses (n=2)
(table 1, online supplemental table 2). There were no
studies examining YFV. Included studies consisted of 2
cohort studies,16 17 4 case–control studies,18–21 27 cross-
sectional studies,22–48 1 nested cross-sectional study within
a cohort,49 1 combined cross-sectional and cohort study50
and 1 longitudinal serosurvey.51 Studies were conducted
in 23 countries: 4 in low-
income countries (Burkina
Faso,42 Laos35 and Sudan26 43), 14 in lower-middle-income
countries (Ecuador,41 India,19 Jordan,33 37 Kenya,17 36
Nicaragua,16 50 Nigeria,27 31 40 Pakistan,39 Sri Lanka18 and
Vietnam34), 13 in upper-middle income (Brazil,23 30 45–47
China,20 24 38 Colombia,49 51 Malaysia,25 Paraguay44 and
Thailand29) and 5 in high-income countries/territories
Power GM, et al. BMJ Global Health 2022;7:e007735. doi:10.1136/bmjgh-2021-007735

(Mayotte (France),28 French Guiana,21 Saudi Arabia,22
Sweden32 and USA48) according to the Development
Assistance Committee List of Official Development Assistance Recipients (figure 2).
Age and sex
Age and sex were investigated and/or adjusted for in 32 of
the 36 studies on seven arboviruses (CHIKV, DENV, JEV,
RVFV, SINV, WNV and ZIKV). These studies included
three case–control, two cohort, 25 cross-sectional studies,
one study comprising a cross-sectional and cohort investigation50 and 1 cross-sectional nested in a cohort study,
spanning 21 countries.
Of the 20 studies that evaluated the relationship
between age and arboviral infection, 18 (90%) reported
evidence of an association between increasing age and
seropositivity for arboviruses, while four studies (20%)
found statistical evidence of an association between age
and past arboviral infection (DENV23 36 37 and CHIKV50)
in adjusted models.
All 36 studies considered the direct relationship
between sex and arboviral infection or adjusted for sex
in the model. Five (13.9%) of these studies reported
evidence of higher prevalence of arboviruses among
males in crude analyses.28 32 39 45 47 However, statistical
analyses were not provided for every study, and just eight
provided an adjusted point estimate.16 23 34 36 37 47 50 51 A
study conducted in Sweden32 found a crude statistical
association between being male and seropositivity for
SINV; however, on adjusting for age and smoking in
multivariate analyses, neither sex nor age were significant
predictors of seropositivity for SINV. Twenty-four studies
with 28 crude estimates comprising a total of 34 373
3
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June 2006–
March 2007

2009–2010

 Pessanha et al Brazil
(2010)46

Brazil

Paraguay

 Kikuti et al
(2015)45

 Pereira et al
(2015)44

2014–2015

May 2016–
August 2016

 Kenneson et al Ecuador
(2017)41

Nigeria

Pakistan

China

 Nasir et al
(2017)40

 Khan et al
(2018)39

 Liu et al
(2018)38

Jordan
 Obaidat and
Roess (2018)37

May 2004–
September
2004

Burkina
Faso

 Fournet et al
(2016)42

2015–2016

2013–2015

2013–2015

2011

 Soghaier et al Sudan
(2015)43

2014

2004–2006

 da Silva-
Nunes et al
(2008)47

Type of
study

Cross-
sectional

Cross-
sectional

Cross-
sectional

Cross-
sectional

Cross-
sectional

Cross-
sectional

Cross-
sectional

Cross-
sectional

Cross-
sectional

Crosssectional

Cross-
sectional

October 2004– Cross-
November 2004 sectional

Study period

Brazil

 Brunkard et al USA
(2007)48

DENV

Country/
territory

Characteristics of included studies

Author (year)

Table 1

DENV

DENV

DENV

Type of
infection

DENV

0–12 years

All ages

All ages

DENV IgG+

Healthy relatives of patients at
DENV
governmental human health centres at 11
governorates

DENV RT-PCR+

0–80 years

All ages

All ages

DENV NS1 RDT+; 1–49 years
DENV IgG+

DENV NS1 RDT+, All ages
RT-PCR+ and/or
IgM+

DENV IgG+

DENV IgG+

DENV IgG+

DENV IgM+;
DENV IgG+

DENV

DENV

DENV

DENV

All ages

All ages

All ages

892

2085

59 765

171

219

3015

540

418

2962

709

405

600

Total
Age range size

DENV IgM+ and/ >5 years
or RT-PCR+

Not specified

DENV IgG+

DENV IgM+;
DENV IgG+

Diagnostic test

Samples selected from a 200,000-sample DENV
database holding serum collected from
community residents living in Liwan and
Yuexiu districts of Guangzhou

DENV patient samples

Patients with febrile illnesses seeking
medical assistance at hospital

Individuals with DENV infections from
sentinel clinics - as well as members
of the same household and four
neighbouring households located within
200 meters

Children from Ouagadougou districts
with different types and degrees of
urbanisation

Randomly selected community population DENV
through multi-stage cluster sampling

Inhabitants of three villages

Individuals seeking medical care for acute DENV
febrile illness at the only public emergency
health unit

All residents aged over 1 year in the three
Belo Horizonte districts (Venda Nova, DS
Leste and DS Centro-Sul)

Households in Ramal do Granada, were
visited between March and April 2004.
466 dwellers <1–90 years of age (98.5%
of the 473 areas permanent residents)
were enrolled.

Probability-based, household selection
stratified, multistage, cluster-sampling
design

Population

P

P

I

P

P

P

P

P

I

P

P

P

6

5

NOS

5

24.6%

3.98%;
11.8%

9.2%

8.8%;
43.3%

36.5%

22.7%

9.4%

Continued

6

3

4

3

5

6

6

24.2% (95% 5
CI 20.2% to
28.6%)

22.0%

11.9% (95% 5
CI 9.7% to
14.6%)

18.3%

2%–7.3%;
40%–78%

Frequency Cumulative
measure
incidence
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Sri Lanka

 Udayanga et
al (2018)18

Malaysia

Sudan

Nigeria

India

 Abd-Jamil et
al (2020)25

 Eldigail et al
(2020)26

 Omatola et al
(2020)31

 Swain et al
(2020)19

Longitudinal
serosurvey

Type of
study
School children

Population

Cross-
sectional

Colombia

Brazil

 Rueda et al
(2019)49

 Anjos et al
(2020)30

2016–2017

2014

Nicaragua March 2015–
April 2016

2008

2005–2006

2017

2019

August 2017–
May 2018

2007–2010

2015

Cross-
sectional

Cross-
sectional
nested in
community
cohort

Cross-
sectional;
Cohort

Cross-
sectional

Cross-
sectional

DENV

DENV

Type of
infection

DENV

DENV

DENV

DENV

All households of 3 contiguous valleys in
Pau da Lima who are ≥5 years of age

548 suspected CHIKV patients from the
COPCORD cohort

Children aged 2–14 years enrolled in the
Paediatric Dengue
Cohort Study; Household recruitment

Residents aged 18 years or more from
three villages

CHIKV

CHIKV

CHIKV

CHIKV

Household-based; complex multistage
CHIKV
cluster sampling of population of Mayotte

DENV

Visiting outpatients from the four hospitals DENV
in Anyigba

Eleven localities of Kassala state

Orange Asli populations residing in eight
different villages in the forest or forest
fringe areas of Peninsular Malaysia

850 participants from seven selected
communities in Guangzhou with no
reported dengue cases before 2014

Residents of Vila Toninho neighbourhood

Residents of the four cities of all genders, DENV
age groups, and socioeconomic classes

Case–control Confirmed dengue patients within 1 year
in six districts of the state

Cross-
sectional

Cross-
sectional

Cross-
sectional

Cross-
sectional

October 2015– Cross-
March 2016
sectional

2017

February 2017– Case–control Random selection of 200 households
April 2017
reporting past dengue incidence and 200
non-dengue reported households

2010–2012

Study period

 Kuan et al
(2016)50

 Nakkhara et al Thailand
(2013)29

 Sissoko et al
(2008)28

Mayotte

China

 Jing et al
(2019)24

CHIKV

Brazil

 Chiaravalloti-
Neto et al
(2019)23

 Al-Raddadi et Saudi
Arabia
al (2019)22

Colombia

 Piedrahita et
al (2018)51

Country/
territory

Continued

Author (year)

Table 1

CHIKV IgM+,
CHIKV IgG+

CHIKV IgG+

CHIKV total
antibody+

CHIKV IgG+

CHIKV IgG+

DENV IgM+

DENV IgG+

DENV IgG+

DENV IgG+

DENV IgG+

DENV IgG+

DENV IgG+

 N/A

DENV IgG+

Diagnostic test

All ages

>18 years

2–14
years; >15
years

>18 years

≥2 years

All ages

All ages

All ages

All ages

1-84y

>10 y

All ages

All ages

5–19 years

P

P

N/A

P

P

P

P

P

P

N/A

I

1772

548

P

P

5

6

8

3

6

6

6

8

6

4

5

NOS

11.8%

53.8%

Continued

4

4

6.1% (2-14 9;
years);
5
13.1% (>15
years)

61.9%

37.2%

N/A

20.5%

11.4%

17.0%

6.6%

74.6%

26.7%

N/A

53.8%
(2010) to
64.6%
(2012)

Frequency Cumulative
measure
incidence

3362; P
848

507

1154

767

200

600

491

850

1322

6397

4000

4385

Total
Age range size
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Jordan

 Obaidat et al
(2019)33

Viet Nam

Laos

Kenya

French
Guiana

 Bartley et al
(2002)34

 Conlan et al
(2015)35

 Ochieng et al
(2015)36

 Bonifay et al
(2017)21

Multiple arboviruses

Cross-
sectional

March 2013–
June 2014

2007

January 2009–
March 2009

April 1996–
August 1997

Case–
controlE

Cross-
sectional

Cross-
sectional

Cross-
sectional

Cohort

Type of
infection

DENV;
JEV

ZIKV

WNV

SINV

Group of patients infected with CHIKV in
2014 with a group infected with DENV

HIV-negative blood specimens from the
2007 Kenya AIDS Indicator Survey

CHIKV;
DENV

CHIKV;
DENV;
RVFV

Random selection of 14 households per
JEV;
village and all household members over 6 DENV
years age asked to participate

Community and hospital-based subjects

Laboratory-confirmed Zika index cases
and their household members

Healthy relatives of patients seeking
healthcare at health centres throughout
Jordan.

Randomly selected from population
registers

JEV

Febrile participants at five hospitals in
CHIKV
Anyigba who test negative for typhoid and
malaria

Population

Case–control Active case finding in hospitals in Gusi
County, Henan, China

Cross-
sectional

Type of
study

November
Cross-
2015–May 2016 sectional

2009

June 1991–
September
1991

2018

Study period

Nicaragua August 2016–
 Burger-
October 2016
Calderon et al
(2018)16

ZIKV

WNV

Sweden

China

Nigeria

 Ahlm et al
(2014)32

SINV

 Luo et al
(1995)20

JEV

 Omatola et al
(2020)27

Country/
territory

Continued

Author (year)

Table 1

15–64
years

≥6 years

All ages

All ages

15–50
years

25–75
years

>6 months
- 10 years

All ages

336

1091

1136

308

142

801

1729

150

243

Total
Age range size

CHIKV RT-PCR+; >15 years
DENV IgM+
and 3
months

CHIKV IgG+;
DENV IgG+;
RVFV IgG+

NC; JEV HI+;
DENV1 HI+;
DENV2 HI+;
DENV3 HI+;
DENV4 HI+

DENV or JEV
IgG+

ZIKV RT-PCR+

WNV IgG+

SINV IgG+

JEV IgG+

CHIKV IgM+,
CHIKV IgG+

Diagnostic test

N/A

P

P

P

I

P

P

N/A

P

5

8

6

6

8

3

NOS

N/A

0.97%;
12.5%;
4.5%

Continued

6

3

67.3% (Any 4
flavivirus);
39.4% (JEV);
2.2% (DENV
1); 0.8%
(DENV2);
0.8%
(DENV3);
13.6%
(DENV4)

66.0%

31.0%

8.6%

2.9%

N/A

34.2%

Frequency Cumulative
measure
incidence
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*The authors report it was not possible to distinguish between DENV and JEV IgG due to cross-reactivity.
CHIKV, Chikungunya virus; DENV, Dengue virus; HI, Hemagglutination inhibition; I, Incidence; Ig, Immunoglobulin; JEV, Japanese Encephalitis virus; N/A, not applicable; NC, not clear; NOS, Newcastle-
Ottawa scale; NS1, Non-structural protein 1; P, Prevalence; RDT, Rapid diagnostic test; SINV, Sindbis virus; WNV, West Nile virus; ZIKV, Zika virus.

6
3.7%
P
1604
All ages
Flavivirus, CHIKV IgG+;
CHIKV;
DENV IgG+
DENV
Acutely ill children presenting at one of
four healthcare centres
December
Cohort
2014–
December 2015
Kenya
 Hortion et al
(2019)17

NOS
Frequency Cumulative
measure
incidence
Total
Age range size
Diagnostic test
Type of
infection
Population
Type of
study
Study period
Country/
territory
Author (year)

Continued
Table 1
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individuals were included in the random-effects meta-
analysis of the association of sex and arboviral infection.
The crude combined RR for males was 1.1 (95% CI 1.0
to 1.2), with substantial heterogeneity between studies
(I2=63.4%) (figure 3A). Disease-specific pooled estimates
indicated a RR of 1.1 (95% CI 1.0 to 1.3) and 1.0 (95% CI
0.9 to 1.2) in CHIKV and DENV subgroups, respectively.
Education and occupation
The association between education and arboviral infection was analysed in 1 cross-sectional study nested in a
cohort, 2 case–control and 22 cross-
sectional studies,
spanning 18 countries and 6 arboviruses (CHIKV, DENV,
JEV, RVFV, SINV and WNV). In these studies, education
was classified in distinct ways depending on context, and
included level of education,19 24 26 27 29 31–34 36 38–41 43 44 49
schooling age,23 parental education,20 the attainment of
any formal education,25 37 42 length of education in years28
and illiteracy.30 45
Overall, there tended to be a higher risk of infection among less educated individuals in crude analyses.
However, studies that developed multivariate models
indicated weak or no statistical evidence of an association between education and arboviral infection after
accounting for confounding factors.19 20 23 32 36 37 In addition, a cross-sectional study conducted in China presented
evidence that fewer years of parental schooling was associated with increased risk of JEV infection;20 however,
on adjusting for JEV vaccination, there was very little
evidence remaining. In the 17 investigations (n=15 760)
included in the random-effects meta-analysis for education, the crude combined RR for lack of education was
1.5 (95% CI 1.3 to 1.9); however, there was considerable
heterogeneity between studies (I2=83.1%) (figure 3B).
Random-effects meta-analysis for disease-specific
pooled estimates revealed that individuals with no education had a crude combined RR of 1.5 (95% CI 1.2 to
1.8) for DENV infections and 1.1 (95% CI 0.9 to 1.4) for
CHIKV infections.
Occupation was assessed in 11 cross-sectional studies
and 1 case–control study. Eleven of the 12 studies
presented frequencies, 6 presented crude effect estimates and 2 presented adjusted effect estimates. The
occupation-related variables analysed were employment
status,25 26 30 location of work (inside or outside),23 earnings (above the country’s minimum wage or not),41
employment stability and occupation types.19 27–29 31 40 44
In a study conducted by Chiaravalloti-Neto et al in Brazil,
there was a crude association between working outside
and seropositivity for DENV, which was lost on adjusting
for other socioeconomic and demographic covariates.23
Swain et al indicated evidence to suggest that DENV infection was associated with occupations that required travel
into certain parts of India.19 Collectively, in the six studies
(n=4056) that were included in the random-
effects
meta-analysis for occupation, there was little evidence
of an association between lack of employment and arboviral infection (pooled RR 0.9; CI 95% 0.7 to 1.3), with
7
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Figure 2 Geographic distribution of studies included in the systematic review. (A) All countries reporting SEP and arboviral
infections, (B) Countries reporting SEP and Dengue virus (DENV) infections, (C) Countries reporting SEP and Chikungunya virus
infections, (D) Countries reporting on SEP and Japanese encephalitis virus (JEV), Rift Valley fever virus (RVFV), Sindbis virus
(SINV), West Nile virus (WNV), Zika virus (ZIKV) or multiple arboviral infections. SEP, socioeconomic position.

considerable heterogeneity between studies (I2=75.6%)
(figure 3C).

contexts, a meta-analysis was not possible for income or
social vulnerability factors in this study.

Income poverty and social vulnerability
Variables indicating income poverty and social vulnerability varied considerably and thus were challenging to
standardise; however, descriptive analyses indicate that
lower income was a risk factor for arboviral infection,
with limited empirical evidence.
The relationship between poverty or social vulnerability and arboviral infection was assessed in 1 cohort,
4 case–controls and 15 cross-sectional studies, across 16
countries and 4 arboviruses (CHIKV, DENV, JEV and
WNV). Assessments were based on weekly or monthly
household income,18 20 23 25 26 33 39 44–46 48 49 SEP categorised
into groups,42 49 50 per capita income quartiles or quintiles.35 36 47 Health vulnerability was also assessed in two
studies.21 46 This comprised estimating a health vulnerability index and health vulnerability through state or free
care compared with social security and complimentary
health insurance. Frequencies and/or effect estimates
were extracted for 14. Four studies investigating DENV
found evidence of a relationship between lower household income and increased arboviral infection.25 45 47 48
One case–control study, conducted in French Guiana,
that specifically examined healthcare coverage status
in relation to CHIKV and DENV infection, found that
a lack of private health insurance was associated with
higher CHIKV infection both in the crude and adjusted
analyses. In contrast, however, DENV appears to affect
a wealthier population.21 Since poverty indicators were
not measured consistently between studies and study

Household conditions
Four case–control, three cohort, one longitudinal serosurvey and 18 cross-
sectional studies investigated the
association between household characteristics and arboviral infections. These studies examined the type or
size of residence,19 22–24 30 32 34 44 46 house appearance or
quality,20 28 42 number of rooms,22 41 building density,42
household crowding,17 18 22 23 28 30 31 41 43 44 48 50 type or
presence of walls,47 wall gaps,47 presence of screens,41 48
residential area,17 21 32 37 waste management42 45 and asset
ownership (air conditioning,48 refrigerator,16 television,34
land tenure and home ownership23 41 47 and asset ownership index (presence of electricity, flush toilet, piped
water and possession of a television set, radio or refrigerator).28
Of the four studies that evaluated the association
between type of residential area (urban vs rural) and
arboviral infections,17 32 34 37 one reported higher risk
of SINV infection in small, rural residential areas in
Northern Sweden,32 one study showed that the risk of
flavivirus infection was higher in urban residential areas
or cities compared with surrounding rural areas and
Southern Vietnam,34 while a study in Kenya observed
no difference in flavivirus infection between rural and
urban areas but did note a higher seroprevalence among
coastal compared with western study participants.17 In
Jordan, a higher risk of WNV infection was reported
for those living in Badia and the Jordan Valley regions
(arid and hot climates) compared with those living in the

8
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Figure 3 Meta-analysis for the association between socioeconomic risk markers and arboviral infections. Pooled estimates using random-effects meta-analyses
are calculated by subgroups of socioeconomic markers, sex (A), education (B), employment (C), water supply (D) and marital status (E). Subgroups of arboviruses are
additionally presented per risk marker. Error bars show the point RR with their 95% CIs on the log scale for each study. Diamonds show the combined point estimate. I2
statistics and Q-test p values are reported. *Indicates cohort study, whereas all others are cross-sectional studies.
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Highlands and Plains regions (colder and higher precipitation areas).37
The relationship between house or land ownership and
arboviral infection was evaluated in three studies.23 41 47
A cross-sectional study conducted in Brazil showed little
evidence of an association between home ownership
and seropositivity in DENV, although living in a house
compared with an apartment was positively associated
with DENV seropositivity, after adjusting for socioeconomic and demographic covariates.23 Crude analyses
indicated evidence of a negative association between land
tenure in rural Amazonia, Brazil, and DENV seropositivity; however, this association was weak in the adjusted
analysis.47
Of the seven studies that analysed building materials,
three studies found an association between poor building
materials or structures and arboviral infection.20 28 30 In
addition, unstructured low building density households
had higher prevalences of CHIKV and DENV.19 20 28 42
Crowding, categorised by number of individuals per
household,17 22 23 28 30 43 44 48 50 residents per room41 or
residents per bed27 was analysed in 11 studies, of which
four found an association between crowding and arboviral infection.23 28 43 50 In a study conducted in Paraguay,
DENV prevalence was higher for those who lived alone
compared with those who lived with others.44
Water supply and sanitation
Water supply or service consumption was investigated in
eight studies16 22 37 41–44 50 and waste collection or sanitation in three studies.22 42 48 Having adequate water supply
(ie, tap or piped water) was associated with lower DENV
infection in Ecuador41 and Paraguay.44 In addition,
water supplied by water wells, onsite water storage and
frequent/longer interruptions of water supply was associated with higher flavivirus seroprevalence in Burkina
Faso,42 higher seropositivity for ZIKV in contacts of ZIKV
index cases in Nicaragua,16 higher DENV infection in
Ecuador41 and Saudi Arabia,22 and higher CHIKV infection in children in Nicaragua.50
Improper waste management practices were also significantly associated with flavivirus IgG in different building
density strata in Burkina Faso,42 while an association was
found between lack of street drainage and higher DENV
infection on the US/Mexico border.48 The absence of
sanitation was strongly associated with DENV infection
in crude analysis in Saudi Arabia; however, this was not
included in the multivariable analysis.22 The random-
effects meta-analysis from three studies (one of which
contained a cohort (A) and cross-
sectional (B) study
design) (n=10 196) revealed evidence of an association
between interruption of water supply and arboviral infection (RR 1.2; 95% CI 1.1 to 1.3; I2=0.0%) (figure 3D).
Other (marital status, ethnicity and migration status)
A range of other sociodemographic factors that act as
proxies for SEP were investigated by several articles
identified in this review. Having been born overseas was
10

associated with greater risk of past arboviral infection,
evidenced by one study,21 and crude analyses indicated
individuals who identified as non-white or of a schedule
caste in India, had a higher risk of arboviral infection.19 23 45 49 The evidence was limited, concentrated in
six countries and largely focused on DENV or CHIKV.
Having been married, including currently or previously
(ie, divorced or widowed), was associated with an overall
increase in risk of arbovirus infection.23 31 38 Marital status
and its association with DENV and CHIKV IgG and/
or IgM antibody levels was investigated in four cross-
sectional studies, conducted in Guangzhou, China,38 São
Paulo, Brazil,23 Guinea Savannah, Nigeria,31 and Kogi
state, Nigeria.27 In São Paulo,23 adjusted analyses showed
that being single was a risk factor for DENV compared
with being married, while in Guangzhou, China,38 crude
analyses showed that widowed or divorced individuals
were at higher risk of infection compared with both their
married and single counterparts. Adjusted analyses from
these two studies, however, revealed no statistical evidence
of an association. All four studies were included in the
random-
effects meta-
analysis, which revealed statistical
evidence that individuals who had ever been married,
including currently married, divorced or widowed, had
higher overall crude risks of arboviral infection (RR 1.5
95% CI 1.1 to 2.1; I2=85.2%) than those who were single
(figure 3E).
Four studies examined race/caste as a correlate of arboviral infection, of which two were conducted in Brazil,23 45
one in Colombia49 and one in India.19 The two Brazilian
studies found that Black and non-white individuals were
at increased risk of DENV23 45 and a case–control study
conducted in Odisha, India, revealed higher odds of
DENV infection in those considered a schedule caste
or schedule tribe (official term given in India to those
who have historically faced deprivation, oppression and
marginalisation) compared with those considered non-
schedule caste or non-schedule tribe.19 The crude analyses showed evidence of this association; however, this
was lost on adjusting for unmentioned confounders. A
meta-analysis was not performed due to the heterogeneity of study contexts and the countries’ specific social
constructions of race/caste.
Migration status, defined on the basis of the country
of birth: French-born and Foreign-born, was investigated
as a potential risk factor for arboviral infection in a case–
control study conducted in French Guiana.21 This study
found strong statistical evidence in crude analysis that
individuals born abroad had over four times the odds of
testing positive for DENV IgG than those born in French
West Indies, French Guiana or Mainland France. One
study additionally indicated that changing city within
Brazil was not associated with an increase in DENV infection risk.46
Quality evaluation
The quality scores of the 36 individual studies varied
across study designs. For cross-sectional studies, scores
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ranged from 3 to 6, with weaknesses related to selection bias of exposed cohorts and lack of adjustment for
confounders. For the cohort studies, scores ranged from
6 to 9, with weaknesses related to no indication of absence
of disease at the start of the study and to lack of adjustment for confounders (online supplemental table 1A).
For case–control studies, scores ranged from 4 to 8, with
weaknesses related to lack of adjustment for confounders
(online supplemental table 1B).

DISCUSSION
In this systematic review and meta-analysis, we summarised published evidence linking markers of SEP and
infection due to arboviruses with mosquito vectors.
Descriptive results indicated lower education, income
poverty, low healthcare coverage, poor housing materials, interrupted water supply, marital status (married,
single, divorced or widowed), non-white ethnicities and
migration status as potential risk factors for arboviral
infection. Meta-analyses provided statistical evidence of
an increased risk of infection due to arboviruses with
mosquito vectors associated with lack of education, interruption of water and having ever been married.
Overall, the seroprevalence of arboviral-specific antibodies (in particular, to DENV) was shown to be highest
in older age groups. This finding corroborates a number
of studies that found a positive association between age
and seropositivity for DENV and is assumed to be related
to the longer period of exposure to DENV over time.52–58
No clear association between arboviral infection and sex
was observed.
In addition, individuals with lower education were at
greater risk of arboviral infection in both the descriptive
summary and meta-analysis. Education is commonly used
as a generic indicator for SEP, highlighting the accumulation of advantage and disadvantage over the lifecourse.59 60
It is associated with permanent income status, whereas
income itself, for example, captures the level of income
at the time of data collection and is thus, in general, volatile. These findings, therefore, might suggest that structural poverty is a relatively more important factor than
transient poverty. Education is also argued to capture the
knowledge and skill-related assets of an individual, which
may contribute to the receptivity of health messaging
and thus permitting more informed use of vector control
activities to reduce risk of infection.61
The descriptive analysis for employment assessed
several occupations and occupational exposure types,
while the meta-
analysis looked at unemployment
compared with being employed. No overall statistical
evidence for unemployment as a risk factor for arboviral
infection was apparent. The unobserved effect is likely
because the degree of vulnerability linked to unemployment is highly dependent on both the type of employment (indoor or outdoor occupations) as well as the
country’s overall economic circumstances.59 Thus, this
Power GM, et al. BMJ Global Health 2022;7:e007735. doi:10.1136/bmjgh-2021-007735

indicator is limited when comparing across studies as well
as geographic areas.
Poverty has long been considered a determinant of
arboviral infections such as DENV and CHIKV; however,
the scarcity of studies with consistent measures of income
poverty and social vulnerability has meant that such a
relationship has yet to be substantiated. Indeed, in this
systematic review, a meta-analysis was not possible for the
variables that indicated income poverty and social vulnerability, since contexts within which the data were collected
for these were not standardised. Descriptive analyses,
nonetheless, indicated that lower income appeared to be
a risk factor, although with limited empirical evidence.
This is additionally supported by the vast literature on
social determinants of health.62 Income can influence a
variety of material circumstances with direct implications
for health and arbovirus exposure.63 The conversion of
money and assets into health-enhancing commodities or
behaviours may be more relevant to understanding how
this variable affects arboviral infection directly.59
While a meta-analysis was not completed for the variables related to the constructs of race or caste, the descriptive analysis revealed that individuals who identified as
non-white23 45 or of a schedule caste19 were at greater risk
of arboviral infection. While there is no biological basis
for an association between these constructs and health,64
ethnicity, caste and race are proxies for the embodiment of xenophobia, casteism and racism in their structural, cultural and interpersonal forms.65 Data from the
US context, for example, observed that in areas where
mortality rates are highest, the fraction of black residents is larger.66 These findings may be extrapolated to
the Brazilian context, where racial inequality and segregation are reflected in social disadvantage65 and health
inequities.
Substandard housing conditions are likely to lead to
greater exposure to mosquitoes and thus increased risk of
infection.67 The association between poor quality housing
conditions and arboviral infection was a common finding
in many of the studies assessed. However, due to the
diversity of indicators relating to household conditions,
it was not possible to evaluate this in a meta-analysis.
Poor living conditions are often also characterised by
overcrowding. Indeed, household crowding appeared to
be an additional risk factor for DENV infection. While
the reasons behind this are unknown, it is likely due to
the association between household crowing and income
poverty as well as to the higher concentration of carbon
dioxide and other chemicals in crowded houses which
attracts a greater number of mosquitoes.68 Furthermore,
the meta-analysis conducted on water supply in this study
provided evidence that interruption in water supply, likely
resulting in storage of water in containers and creation of
prime breeding spots for mosquitoes,69 may increase risk
of CHIKV and DENV infection.
The meta-analysis provided evidence that having been
married, including currently or previously (ie, divorced
or widowed), was associated with an increase in arboviral
11
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infection risk; however, the descriptive analysis indicated
that most of these associations diminish after adjusting
for confounding. Age may be a particularly important
confounder in this context. Migration was assessed in one
study and presented descriptively in this analysis. Those
classified as migrants were considered to be in a precarious social situation, since they did not have regular social
security and health insurance and therefore were more at
risk of arboviral infection.21
This review has strengths and limitations. First, it is
among the first to conduct a systematic review and meta-
analysis using diverse populations to assess SEP indicators
that identify individuals at the highest risk of arboviral
infection. Further research is required to understand the
specific mechanisms by which these factors impact infection. The findings of this review should be interpreted
with caution, since there were high levels of heterogeneity
between studies, which is likely a result of differences in
study design, study population and contexts within which
these data were collected as well as differences inherent
to the individual arboviruses and their mosquito vectors.
While this review addressed several arboviruses that
circulate in different ecological cycles and involve differences in vector-host preferences, local host abundances
and herd immunity, assessing the social determinants
of these arboviruses together allows for the analysis of
distal risk factors, such as socioeconomic indicators, that
have an overarching effect on all arboviral infections.7
However, we acknowledge that grouping findings from
multiple arboviruses may obscure observations and the
heterogeneity of the measures used to capture the range
of socioeconomic factors analysed in these studies make
it more difficult to delineate associations of interest.
Furthermore, this review did not differentiate past infections from current infections and therefore changes in
SEP, civil status and even location may have introduced
misclassification bias.

on the socioeconomic determinants of infection due to
arboviruses with mosquito vectors and emphasise the
need for further research to disrupt the cycle of poverty,
vulnerability and arbovirus-related illness.
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Supplementary Material 1. Search strategy used to study socioeconomic factors associated with
arboviruses
Pubmed

("Arboviruses"[Mesh] OR "Arbovirus Infections"[Mesh] OR "Zika Virus"[Mesh] OR "Zika Virus
Infection"[Mesh] OR "Dengue"[Mesh] OR "Severe Dengue"[Mesh] OR "Dengue Virus"[Mesh] OR
"Chikungunya Fever"[Mesh] OR "Chikungunya virus"[Mesh] OR "Encephalitis, Japanese"[Mesh]
OR "Encephalitis Viruses, Japanese"[Mesh] OR "Encephalitis Virus, Japanese"[Mesh] OR "Rift
Valley Fever"[Mesh] OR "Rift Valley fever virus"[Mesh] OR "West Nile virus"[Mesh] OR "West Nile
Fever"[Mesh] OR "Yellow Fever"[Mesh] OR "Yellow fever virus"[Mesh] OR zika[Title/Abstract] OR
zikv[Title/Abstract] OR denv[Title/Abstract] OR dengue[Title/Abstract] OR chikv[Title/Abstract]
OR chikungunya[Title/Abstract])
AND
("Social Conditions"[Mesh] OR "Socioeconomic Factors"[Mesh] OR "Social Class"[Mesh] OR
"Poverty"[Mesh] OR "Poverty Areas"[Mesh] OR "Income"[Mesh] OR "Education"[Mesh] OR
"Educational Status"[Mesh] OR "Ethnic Groups"[Mesh] OR "Race Factors"[Mesh] OR
socioeconomic*)
Embase

exp Arbovirus/ OR (Arboviruses or Arbovirus Infections or Zika Virus or Severe Dengue or Dengue
Virus or Chikungunya Fever or Chikungunya virus or Japanese Encephalitis Viruse or Rift Valley
Fever or West Nile virus or West Nile Fever or Yellow Fever or zikv or denv or chikv).mp.
[mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug
manufacturer, device trade name, keyword, floating subheading word, candidate term word]
AND
exp social class/ OR (Social Conditions or socioeconomic* or Social Class or Poverty or Poverty
Areas or Income or Education or Educational Status or ethnic* or race).mp. [mp=title, abstract,
heading word, drug trade name, original title, device manufacturer, drug manufacturer, device
trade name, keyword, floating subheading word, candidate term word]
LILACS

Arboviruses or Arbovirus Infections or Zika Virus or Severe Dengue or Dengue Virus or
Chikungunya Fever or Chikungunya virus or Japanese Encephalitis Viruse or Rift Valley Fever or
West Nile virus or West Nile Fever or Yellow Fever or zikv or denv or chikv [Palavras]
AND
Social Conditions or Socioeconomic$ or Social Class or Poverty or Poverty Areas or Income or
Education or Educational Status or ethnic$ or race or socioeconomic or pobreza or social or
renda or educa$ or raca [Palavras]
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Supplementary Material 2: Inclusion and exclusion criteria

Inclusion Criteria
Types of studies

Types of participants
Types of exposure
measures

Types of outcome
measures

Exclusion Criteria
Types of studies

Dates of studies
Types of outcome
measures

Publication date: 1980 to 2020
Studies from any geographical location.
English, Spanish, Portuguese and French language.
Studies using quantitative methods: Observational case reports, case
series, cross-sectional, case-control and cohort studies.
All ages acceptable.
Socioeconomic position and/or proxy measures of socioeconomic
position at an individual level, such as social class, living conditions,
education, household income, ethnicity if directly linked to
socioeconomic status and asset ownership.
Occurrence of infections due to arboviruses with mosquito vectors

Grey literature / not published in a peer reviewed journal, ecological
study designs/spatial analyses with no indication of individual risk
factors
Treatment guidelines documents, other systematic reviews
<1980s
Economic burden of arbovirus (e.g., economic evaluation of costs of
disease to families or governments).
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Supplementary Table 1. Bias assessment using the Newcastle-Ottawa scale (NOS) for individual-level studies for cross-sectional and cohort (A) and case-control (B)
Author(s)

Year of

Selection (4)

Comparability (2)
Demonstration That
Outcomes of
Interest was Not
Comparable in
Present at Start
Main Factor (age)
1

Outcome (3)

Comparability in
other controlled
factors (i.e. sex)
1

Assessment of
Outcome
1

Total Score

Study design

Abd-Jamil, J., et al.

2020

Representativeness of the
Exposed Cohort
1

Selection of the
Non-Exposed
Ascertainment
Cohort
of Exposure
1
1

Ahlm, C., et al.

2014

1

1

1

1

1

Al-Raddadi et al

2019

1

1

1

1

1

Anjos et al

2020

1

1

1

0

Bartley, L.M., et al.

2002

0 (only typhoid patients)

1

1

Brunkard, J. M., et al.

2007

0 (more females than male)

1

1

Burger-Calderon, R., et al.

2018

1

1

1

Chiaravalloti-Neto, F., et al.

2019

1

1

1

Conlan, J. V., et al.

2015

1

1

1

0

0

1

4

Cross-sectional

Da Silva-Nunes, M., et al.

2008

1

1

1

1

1

1

6

Cross-sectional

Eldigail, M. H., et al

2020

1

1

1

1

1

1

6

Cross sectional

Fournet, F., et al.

2016

1

1

1

1

1

1

6

Cross-sectional

Hortion, J., et al.

2019

0 (only acutely ill patients in
hospital)

1

1

0

0

1

6

Cohort study

Jing, Q., et al.

2020

1

1

1

1

1

1

6

Cross sectional

Kenneson, A., et al.

2017

0 (1/3 of cases are referred
from MOH health facilities)

1

1

1

1

1

5

Cross-sectional

Khan, J., et al.

2018

1

1

1

2015

0 (only acutely febrile
patients)

1

1

0
1

0
1

1

Kikuti, M., et al.

4
5

Cross sectional
Cross-sectional

Kuan, G., et al.

2016

1

1

1

1

1

1

9

Community based
cohort (0-14)

5

Cross-sectional (>15 yo)

0 (more females)
Liu, J., et al.

2018

1
1

1
1

1
0

1
1

3

Cross-sectional

Sufficient period
of follow up

Adequacy of
follow up
6

Cross sectional

1

6

Cross-sectional

1

6

Cross sectional

0

1

4

Cross sectional

1

1

1

5

Cross-sectional

1

1

1

5

Cross-sectional

0

1

1

1

1

1

8

Cohort

0

1

1

1

1

1

8

Cross-sectional/cohort

1

1

1

1

1
0

1

1

Study description

1

Nakkhara, P., et al.
Nasir, I. A., et al.

2013
2017

0 (more females)
0 (more females)
0 (patients with febrile illness)

1
1

1
1

1
0

1
0

1
1

5
3

Cross-sectional
Cross-sectional

Obaidat, M. M. and A. A. Roess

2018

1

1

1

1

1

1

6

Cross-sectional

Obaidat, M. M., et al.
Ochieng, C., et al.

2019
2015

1
0 (only HIV negative samples)

1
1

1
1

1
1

1
0 (did not adjust
for sex)

1
1

6
3

Cross-sectional
Cross-sectional

Omatola, C. A., et al.

2020

1

1

0

0

1

3

Cross-sectional

Omatola, C. A., et al.

2020

1

1

0

0

1

3

Cross-sectional

Pereira, Y., et al

2015

0 (Only included patients who
had fever and suspected
typhoid or malaria)
0 (Only patients with febrile
illness were included)
1

1

1

1

0

1

5

Cross-sectional

Pessanha, J.E.M., et al

2010

1

1

1

1

0

1

5

Cross-sectional

Piedrahita, L. D., et al.

2018

1

1

1

1

0

1

5

Cross-sectional

Rueda, J. C., et al

2019

1

1

1

0

0

1

4

Cross-sectional

Sissoko, D., et al.

2008

1

1

1

1

1

1

6

Cross sectional

Soghaier, M. A., et al.

2015

1

1

1

1

1

1

6

Cross-sectional

This present study was performed to
investigate the seroprevalence of dengue
among the Orang Asli (OA) residing at the
forest fringe areas of Peninsular Malaysia and
determine the factors that could affect the
transmission of dengue among the OA.
Seroprevalence study to determine
seroprevalence of SINV and associated risk
factors.
To estimate the seroprevalence of dengue in
these regions and the risk factors associated
with positive serology
Investigate factors associated with prior CHIKV
infection
Study assesses associations between
sociodemograpgic factors and dengue and
Japanese encflavivirus seroprevalence in
Southern Vietnam.
Cross-sectional serosurvey used to assess
dengue seroprevalenceon the southern TexasMexico border and assess assocaited risk
factors
Study assessing the prevalence of ZIKV and its
social determinants in Nicaragua.
Seroprevalence study to determine
seroprevalence and incidence of DENV and
identify if SES and demographic covariates are
associated with seropositivity.
Seroprevalence study to determine
seroprevalence of flaviviruses (JEV and DENV)
and associated risk factors.
Seroprevalence study to determine
seroporevalence of DENV in Amazonas region
of Brazil and associated risk factors
In the present investigation, a cross sectional
study was conducted to advance an
understanding of the prevalence of DENV and
associated risk factors were determined in
Kassala State, Sudan.
Seroprevalence study to analyse flavivirus
prevalence relative to the socioeconomic,
demographic, health and environmental data
concerning children, their family and
household and the district.
This seroprevalence study aimed to
investigate the frequency of alphavirus and
flavivirus incident infections in two regions in
Kenya and identify potential risk factors
A cross-sectional serosurvey using a stratified
random sampling method among individuals
aged 1–84 years-old in 7 communities in
Guangzhou with no reported dengue cases
before 2014 was performed.
The authors conducted a household-level
study to identify KAP and social-ecological risk
factors associated
with acute or recent DENV infections in the
city of Machala, Ecuador.
Conducted enhanced, community-based
surveillance in the
only public emergency unit in a slum in
Salvador, Brazil to identify acute febrile illness
(AFI)
patients with laboratory evidence of dengue
infection.
Two studies were conducted to analyse the
seroprevalence of CHIKV after the first
chikungunya epidemic in a community-based
cohort of children ages 2-14 years and a crosssectional survey of persons over 15 years old
in the same are of Managua, Nicaragua.

This cross-sectional study explored the seroprevalence of dengue virus infection in
Guangzhou

Seroprevalence study to understand the
prevalence of DENV in Jordan and ssess risk
factors that may be assoicated with increased
seropositivity.
Seroprevalence study to understand the
prevalence of DENV, CHIKC and RVFC in Kenya
and associated risk factors
This study identifies past exposure to DENV
among people in Anyigba, located in the
Guinea Savannah region, Nigeria.
This study identifies recent CHIKV infection in
Anyigba, Nigeria.
Study to establish the seroprevalence of
infection by the dengue virus in a district of
the Paraguayan Chaco
Study to determine dengue seroprevalence for
to different viral serotypes in three districts in
Belo Horizonte, Brazil
Belo Horizonte
This longitudinal serological survey and spatial
analysis study estimated dengue virus (DENV)
transmission in
schoolchildren (aged 5–19 years) in Medellin
from 2010 to 2012.
The objective of this study was to describe the
demographics and clinical characteristics of
suspected chikungunya cases in six Colombian
cities.
Household-based cross sectional serosurvey to
investigate the association between CHIKV
seropositivity and risk factors
The objective of this study was to identify
socio-demographic factors associated with the
prevalence of dengue
serotypes in Kassala State in the eastern part
of Sudan in 2011.
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Supplementary Table 1. Bias assessment using the Newcastle-Ottawa scale (NOS) for individual-level studies for cross-sectional and cohort (A) and case-control (B)
Author(s)

NOS
Total

Bonifay, T., et al.

Year of
publication
2017
6

Study design

Study description

Luo, D., et al.

1995

8

Case control

Study examines children with Japanese encephalitis and compares them with neighborhood
controls matched by age and sex in terms of several social and environmental variables.

Swain, S., et al.

2019

8

Case-control

Udayanga, L., et al.

2018

4

Case-control

The study aims to identify the social and ecological factors associated with emerging dengue in
Odisha, India.
Evaluation of demographic, socio-economic an dother assoicated risk factors affecting the
occurrence of DENV incidence.

Case (CHIKV)-control (DENV) Study to describe the socioeconomic indicators of individuals infected with CHIKV and compare
to those infected with DENV and the local population.
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Author(s)

Abd-Jamil, J. et
al

Year

2020

NOS

Country

Malaysia

Region

Orang Asli

Study design

Cross-sectional

Study population

Unit of analysis
(Individual or
population)

Study description

Individual

To determine these
factors by
investigating
the potential influence
that demographic and
socioeconomic
variables as well as
land cover and physical
environmental
factors might have on
dengue IgG
seroprevalence

2007-2010

Seroprevalence study
to determine
seroprevalence of
SINV and associated
risk factors.

2009

Study year(s)

Source
population

Total size

SINV

Sex

Age

Diagnosis/sou
rce of data

Test

Frequency
measure

CHIKV
Incidence/Prev
alence

Test

Frequency
measure

DENV
Incidence/Prev
alence

Test

Frequency
measure

JEV
Incidence/Prev
alence

Test

Frequency
measure

ZIKV
Incidence/Prev
alence

Test

Frequency
measure

WNV
Incidence/Prev
alence

Test

Frequency
measure

Any flavivirus or arbovirus
Incidence/Prev
alence

Test

Frequency
measure

Incidence/Prev
alence

RVFV
Test

Frequency
measure

Exposure
Incidence/Prev
alence

Risk
factors/Independent
variables/Indicators
Sex

Orange Asli
populations
residing in eight
different OA
villages in the
forest
or forest fringe
areas of
Peninsular
Malaysia

Age

ELISA

Prevalence

17%

Education

Female

Income

Sex

2014

Sweden

Northern
Sweden

Cross-sectional

Individual

1729

-

25-74

Clinical data

EIA for IgG
Size of residential area

Age group

Sex

Housing type

1

No formal education

Working

2019

Saudi Arabia

Makkah,
Madinah,
Jeddah, Jizan

Cross-sectional

individual

To estimate the
seroprevalence of
dengue in these
regions and the risk
factors associated with
positive serology

Residents of the
four cities of all
genders, age
groups, and SEC

6397

60.4% male,
39.6% female

8.2% from 010, 44.5% from
laboratory data
11-30, 47.2% >
30.

IgG ELISA

Prevalence

26.70%
Number of rooms

Water interruption

Sanitation

Skin color

> RM 500

15 (9.3%)

Males

Salvador

Cross-sectional

individual

Investigate factors
associated with prior
CHIKV infection

2016-2017

All households of 3
contiguous valleys
in Pau da Lima
who are >=5 years
of age and have
slepted >= 3 nights
per week in the
house

Household per capita
income in US$/day
1772

57% female

laboratory data

IgG/IgM ELISA
+ PRNT

prevalence

11.80%

Education

Occupation

Type of residence
construction

Residents/household

Confounders/Adjust
ed for

Positive

1
<0.001

Positive

<0.001

<0.001

1

3.7%

Effect
Positive

4.4

1
2.34 (1.54-3.56)
1

Backwards
elimination

Positive

2.2

Positive

1

p=0.047

2.0%
p=0.14

>15,000

1.3%

100-15000

4.4%

No university studies

Chi2 or
Student's t test

p≤0.001

SINV
seropositivity

Logistic
regression
analysis

1
OR

5.8%
3.5%

p=0.013

Age, sex, smoking

3.4 (1.6-7.3)

p=0.002

Positive

4.3 (2.0-9.2)

<0.001

Positive

1

OR

University studies

1.3%

0-10

60 (11.7%)

1

0.42 (0.17-1.0)

11-30

636 (22.3%)

2.16 (1.63-2.87)

0.054

1
p < 0.001

3.79 (2.86-5.01)

2.10 (1.49-2.96)

p<0.001

3.91 (2.78-5.50)

<0.001

>30

1014 (33.5%)

Male

1057 (27.5%)

Female

653 (25.6%)

-

-

Villa w/o garden

278 (30.1%)

1.93 (1.62-2.31)

1.30 (1-1.69)

0.046

villa with garden

29 (21.9%)

1.25 (0.82-1.92)

0.81 (0.47-1.39)

0.447

Apartment (n=217)

418 (18.2%)

1

1.10 (0.98-1.23)

0.095

1

606 (33.0%)

<0.001

2.21 (1.92-2.55)

341 (32.1%)

2. 12 (1.80-2.51)

Other

5 (29.4%)

1-3

387 (32.4%)

4-6

254 (28.0%)

1.11 (0.77-1.60)

7-10

100 (27.8%)

1.09 (0.73-1.65)

1.87 (0.66-5.34)
DENV
seropositivity

Chi2

OR

-

1.84 (1.56-2.17)

<0.001

Positive

1.82 (1.49-2.21)

<0.001

Positive

1.99 (0.55-7.27)

0.296
Multivariate analysis

0.066

45 (26%)

1

<5

700 (27.9%)

1.33 (1.12-1.58)

1

740 (26.8%)

1.26 (1.06-1.50)

0.86 (0.74-0.99)

11-20

218 (22.6%)

1

>20

52 (31.3%)

1.57 (1.09-2.25)

Regular

843 (25.4)

1

Irregular

717 (29.3)

1.22 (1.09-1.37)

Present

816 (24.9)

1

865 (29.3)

41 (8.1%)

63 (14.9%)

>5.5

Negative

0.71 (0.58-0.88)

0.002

Negative

1.99 (0.55-7.27)

0.708

0.001

0.001

1.25 (1.12-1.40)

93 (12.2%)

104 (11.9%)

>=40

≤5.5

0.007

0.042

p = 0.6

116 (11.5%)

5-14
15-39

Non-white

Positive

Positive

1.37 (0.95-1.96)

>10

Male

Positive

-

1

6-10

White

Brazil

2.92 (2.00-4.27)

2.23 (1.32-3.78)

Female

2020

OR

68 (20.7%)

Absence
Sex

Age group

Logistic
regression

Adj Effect measure (95% CI)

0.023

<0.001

1
DENV
seropositivity

21 (33.9%)
62 (14.5%)

< RM 500

Social house

2017

Number of occupants by
household

Anjos, R. et al

38 (10.6%)
41 (33.3%)
42 (11.4%)

Not working

Popular house

Al-Raddadi

Crude effect measure

4.43 (2.71-7.26)

<1000
Level of education

Crude effect
measure type

1.78 (1.08-2.95)

Age
Random selection
from population
registers

Statistical
analysis

26 (12.4%)
45 (34.6%)

Females

Ahlm, C., et al.

Dependent
variable

57 (20.2%)

Male
>= 13

Formal education
Occupation status

Basic statistical Basic statistical
analysis
analysis

Categories

<=12
Laboratory
data

491

BMJ Global Health

p = 0.35

199 (12.0%)

p = 0.39

10 (9.1%)
171 (12.0%)

p = 0.69

37 (10.9%)

Illiterate

14 (18.4%)

Literate

195 (11.5%)

Yes

60 (9.9%)

No

148 (12.7%)

Plastered wall

154 (10.9%)

Unplastered wall

33 (15.6%)

Wood or other material

21 (19.8%)

1

13 (9.0%)

2-3

89 (13.2%)

4-5

60 (9.0%)

≥6

5 (13.5%)

Chi2

0.06

CHIKV
seropositivity

Poisson
regression

PR

1.60 (0.99-2.60)

N/A

N/A

1
1

0.08

1.28 (0.97-1.68)
1
0.04

1.47 (0.92-2.35)
1.86 (1.06-3.28)

0.31

Age

Bartley, H., et
al.

2002

Vietnam

Southern
vietnam

Cross-sectional

Individual and
household

Study assesses
associations between
sociodemograpgic
factors and dengue
and Japanese
encflavivirus
seroprevalence in
Southern Vietnam.

Sex

Apr 1996- Aug
1997

Community and
hospital-based
subjects recruited
for other sutdy
(thypoid c-c study)

308

Clinical data

DENV/JEV IgG+

Prevalence

66% (95% CI
60.6 - 71.2)

Place of residence
JEV/DENV IgG+

Prevalence

M (n=158)

97 (61.4)

F (n=150)

106 (70.7)

Cao Lanh City (Urban) (n=172)

126 (73.3)

Surrounding district (n=136)

Level of education

18 (72)
116 (65.2)

High school/College (n=105)
Television ownership

Sex

Yes (n=138)

3.15 (1.44-6.85)

Flavivirus
seropositivity

77 (56.6)

No Schooling (n=25)
Primary school (n=178)

Logistic
regression

3.58 (1.45-8.87)

0.74 (0.33-1.64)

1.07 (0.41-2.8)

0.48 (0.30-0.77)

0.50 (0.28-0.89)

OR

69 (65.7)
88 (63.8)

No (n=170)

115 (67.6)

Male

77 (45.8%) vs 91 (54.2%)

0.13

0.72 (0.46-1.12)

p=0.13

0.25 (0.08-0.65)

p=0.002

4.35 (2.69-7.06)

p<0.001

Female
Age group

Migration status

Bonifay, T., et
al.

2017

Case (CHIKV)control (DENV)

French Guiana

Individual

Study to describe the
socioeconomic
indicators of
individuals infected
with CHIKV and
compare to those
infected with DENV
and the local
population.

CHIKV (Apr-Jun
2014) DENV
(Mar-Aug 2013)

Patients who
sought treatment
at hospital for
CHIKV;
Retrospective
collection of
control group of
patients with
acute DENV

<18

6 (3.6%) vs 22 (13.1%)

0.002

>50

67 (39.9%) vs 35 (20.8%)

<0.001

117 (69.6) vs 58 (34.5)

<0.001

Born in France *
Born abroad

Health insurance

168 and 168

-

>15yrs and
3months

Clinical
diagnosis and
laboratory
confirmation

Yes

25 (14.9) vs 14 (8.3)

0.06

90 (53.6) vs 55 (32.7)

<0.001

123 (82.0) vs 69 (44.0)

<0.001

1.92 (0.92-4.16)

p=0.06

2.37 (1.49-3.78)

p<0.001

5.81 (3.35-10.2)

p<0.001

No
CHIKV RTPCR+, DENV
NS1-and IgM -

Social status (CMU (Free
universal health
care)/State medical aid)

DENV IgM+

Neighbourhood

Not precarious

CHIKV vs DENV

OR

Wealthy
Poor $

Precarious social status

No precarious social
status

None

25 (14.9) vs 14 (8.3)

0.06

1.92 (0.92-4.16)

P=0.06

State medical aid (AME)

11 (6.6) vs 6 (3.6)

0.21

1.89 (0.62-6.37)

p=0.21

Free universal health care (CMU)

54 (32.1) vs 35 (20.8)

Social secuity only
Persons with long term illness
(ALD)
Complimentary health insurance

10 (6.0) vs 7 (4.2)

0.45

22 (13.1) vs 88 (52.4)

<0.001

0.02

46 (27.4) vs 18 (10.7)

1.80 (1.07-3.05

0.001

3.14 (1.68-6.04)

p=0.45
p≤0.001
3.2 (95% CI 1.31–7.95, p = 0.01)
2.59 (95% CI 1.58–4.26, p = 0.000)

Past DENV

Brunkard, J.
M., et al.

2007

USA

Texas/Mexico
border

Cross-sectional

Household level

Laboratory

DENV IgM+
(DENV IgG+)

Prevalence

2-7.3% (4078%)

Recent DENV

Air-conditioning

Past DENV
Intact screens

No. of people/household

BurgerCalderon, R., et
al.

2018

Nicaragua

Managua

Cohort

Individual and
household

0.57 (95% CI 0.37–0.87, p = 0.009)

Past DENV
600 (300
households)

Oct-Nov 2004

Study assessing the
prevalence of ZIKV and
Aug-Oct 2016
its social determinants
in Nicaragua.

Participants of
33 laboratory
Nicaraguan
confirmed
Padiatric Dengue
index cases and
Cohort Study
109 household
(PDCS) and
members
national
surveillance

0.58 (95% CI 0.38–0.89, p = 0.014)

Recent DENV

0.98 (95% CI 0.41-2.32, p = 0.959)

Past DENV

1.35 (95% CI 0.93–1.95, p = 0.111)

Recent DENV

0.97 (95% CI 0.80–1.17, p = 0.727)

Past DENV

1.06 (95% CI 0.95–1.19, p = 0.300)
0.79 (0.50-1.24)

Age
Clinical data

RT-PCR

Incidence

31%

Positive
contacts of ZIKV
index cases

Contacts
Owning refrigerator

RR

Onsite water storage
Sex

ChiaravallotiNeto, F., et al.

2019

Brazil

São Paulo

Cross-sectional

Individual

Occupation
Residents of Vila
Toninho
neighbourhood

1322

≥10

Clinical data

DENV IgG+

74.60%

Schooling

House type

1

595 (74.3)

0.99 (0.76-1.29)

0.96 (0.73-1.27)

1.39 (1.21-1.60)

1.43 (1.21-1.70)

White (n=679)

482 (71.0)

non-white (n=535)

381 (78.4)

Not married (n=566)

417 (73.7)

1

1

Married (n=746)

561 (75.2)

1.16 (0.89-1.51)

0.93 (0.70-1.25)

Inside (n=345)

277 (80.3)

1

1

Outside (n=932)

680 (73.0)

0.70 (0.51-0.96)

0.91 (0.63-1.31)

<=7 (n=596)

459 (77.0)

Apartment (n=217)

Owner (n=868)

Conlan, J. V., et
al.

2015

Laos

Northern Laos

Cross-sectional

Individual

Seroprevalence study
to determine
seroprevalence of
flaviviruses (JEV and
DENV) and associated
risk factors.

Jan-Mar 2009

Random selection
of 14 households
per village and all
household
members over
6yrs age asked to
participate

1136

≥6

JEV HI

Prevalence

JEV (54.6%) - of
which 19.1%
JEV only

Prevalence

67.3 (64.670.1)

1
2.02 (1.10-3.73)

0.97 (0.72-1.31)

0.89 (0.78-1.01)

2 to 4 MS (n=881)

<=4 (n=1027)

660 (74.9)

1

Adjusted for
refrigerator
ownership
Positive

Positive
Positibve

Positive

Adjusted for
socioeconomic and
demographic
covariates presumably sex, age,
maritial status, age
(standardised)
schooling, occupation,
income, house type,
home ownership,
hours at home,
number of residents

67 (65.0)
759 (73.9)

1

1

>4 (n=289)

222 (76.8)

1.13 (0.82-1.55)

1.33 0.95-1.86)

Most poor

1.8 (0.0-3.6)

Very poor

1.7 (0.0-3.4)

Poor

3.6 (1.3-5.9)

Less poor

1.6 (0.0-3.2)
2.1 (0.1-4.2)
0.9 (0.0-2.2)
0.4 (0.0-1.3)

Poor

0.4 (0.0-1.2)

Less poor

0.4 (0.0-1.2)

Least poor

2.1 (0.1-4.2)

Most poor

0.5 (0.0-1.3)
0.4 (0.0-1.3)
0.8 (0.0-1.9)
1.6 (0.0-3.2)

Least poor

0.5 (0.0-1.6)

Most poor

8.5 (4.9-12.3)
12.9 (8.6-17.2)

Poor

16.9 (12.2-21.5)

Less poor

21.2 (16.1-26.4)

Least poor

5.9 (2.5-9.2)

Most poor

27.6 (21.7-33.5)

Very poor

37.3 (31.1-43.6)

Poor

48.2 (42.0-54.4)

Less poor

41.6 (35.4-47.8)

Least poor

41.5 (34.4-48.6)

Most poor
DENV and JEV
HI

1
2.04 (1.10-3.78)
1

Very poor

DENV4
(26.1,24.1,24.9
,46.3%)

142 (65.4)
844 (76.4)

0.89 (0.78-1.01)

Poor

Wealth status

1
1.01 (0.76-1.35)

0.91 (0.69-1.21)

Less poor

Clinical data

1
0.80 (0.61-1.03)

332 (75.3)

Very poor

DENV3
(26.1,24.1,24.9
,46.3%)

Posterior mean
fixed effects
(OR)

646 (74.4)

Very poor

Prevalence

Not included in
paper

1

114 (84.4)

Most poor

DENV

N/A

Adjusted for study
design

1.42 (1.08-1.89)

0 to 2 MS (n=135)

Least poor

DENV2
(26.1,24.1,24.9
,46.3%)

1

Non-owner (n=441)

4 MS or more (n=103)
No. of residents

DENV1
(26.1,24.1,24.9
,46.3%)

2.32 (95% CI 1.26, 4.28)

F (n=801)

House (n=1105)

Income

N/A

2.27 (1.24, 4.16)
1

>7 (n=676)

Home ownership

0.68 (95% CI 0.41, 1.13)
1.60 (95% CI 0.83, 3.06)

1.15 (0.59, 2.25)

391 (75)

1.36 (1.04-1.78)

Negative

0.80 (95% CI 0.51, 1.26)

0.70 (0.42, 1.16)
1.61 (0.84, 3.09)

M (n=521)

Age
Race

Matital status
Seroprevalence study
to determine
seroprevalence and
incidence of DENV and
Oct 2015 - Mar
identify if SES and
2016
demographic
covariates are
associated with
seropositivity.

Negative

0.74 (95% CI 0.28–1.96, p = 0.543)

Poisson
regressoin

Sex (Female)

-

Positive
Positive

0.69 (95% CI 0.29–1.65, p = 0.395)

Recent DENV

Street drainage

p=0.02
p=0.001

1.46 (0.49-4.62)
0.14 (0.08-0.24)
Recent DENV

Income (<=$100)
Cross-sectional
serosurvey used to
assess dengue
seroprevalenceon the
southern TexasMexico border and
assess assocaited risk
factors

N/A

Precarious ^

45.2 (38.7-51.8)

Very poor

59.2 (52.9-65.6)

Poor

79.5 (74.5-84.5)
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≥6

HI

70.1)
Less poor

80.0 (74.9-85.0)

Least poor

70.1 (64.2-77.3)

5-14
Age group

Sex

Da Silva-Nunes,
M., et al.

2008

Brazil

Brazilian
Amazonia

Cross-sectional

Individual and
household

Seroprevalence study
to determine
seroporevalence of
DENV in Amazonas
region of Brazil and
associated risk factors

2004-2006

405

Clinical data

DENV IgG+

Prevalence

18.30%

Wealth index (quartiles)

Land ownership

House walls

17.7%
25.8%

>60

33.3%

Male

24.5%

Female

11.4%

1 (Poorest)

30.1%

2

17.1%

3

17.5%

4 (Least poor)

9.1%

Yes

16.8%

No

31.7%

Wood
Brick

Wall gaps

Age group

Sex

Eldigail, M.H.
et al

2020

Sudan

Kassala state

Cross-sectional

individual

To determine the
seroprevalence of
Dengue in Kassala
8/2017-5/2018
state and the
associated risk factors.

11 localities of
Kassala state

Laboratory
data

600

ELISA

Prevalence

8.1%

15-30
31-60

Yes

19.2%
0.0%

0.0%
18 (5.87%)

>18

62 (15.8%)

Female

32 (10.6%)

Male

48 (12.6%)

Illiterate

19 (10.7%)

Primary

30 (12.9%)

Secondary

Informal study

6 (11.3%)

Low (<2000 SDG)
Medium (between 2000 and
3000 SDG)
High (>3000 SDG)

56 (12.7%)

Income

University

Employment

Unemployed

p=0.0004

Chi2 or Fisher
exact test

p=0.001

Chi2 for linear
trend

p=0.0005

14 (9.6%)

2.43 (1.04–5.76)
3.93 (1.75–9.02)
5.65 (1.72–18.65)
2.53 (1.42–4.51)

DENV
seropositivity

Logistic
regression
analysis

OR

Chi2 or Fisher
exact test

Positive

Negative

Migration history and
other covariates

1

Undefined

p=0.032

1
Undefined

p=0.014

1
1

p=0.001

0.001

Positive

0.027

Positive

3.24 (1.81-5.77)
p=0.281

p=0.897
Chi2

DENV
seropositivity

Logistic
regression

Excluded confounders not specified

OR

3.75 (1.57-8.93)
p=0.136
1

33 (11.1%)
47 (11.7%)

p=0.001

2.31 (1.03–4.90)

7 (6.1%)

20.7 (22.4–26.7)

0.88 (0.83-0.95)

1.99 (0.81–4.93)

p=0.033

11 (12%)

Male

p=0.001

-

1.94 (0.80–4.82)

1

17 (11.6%)

Employed

2.60 (1.55-4.43)

1
4.05 (1.74–9.63)

18.5%

No
≥5 and ≤18

Level of education
11.42%

1
Chi2 for linear
trend

p=0.809
UHBD
ULBD

1

SHBD
Sex

SLBD

0.015

0.92 (0.64–1.30)

UHBD
Female

24.4 (18.7–22.8)

ns

ULBD

1.19 (0.85–1.67)

ns

SHBD

1.83 (1.15–2.90)

p<0.05

SLBD

1.25 (0.90–1.74)

ns

UHBD
0-4

ULBD

11.8 (9.8–13.7)

1

SHBD
SLBD
UHBD
Age group

4-10

25.9 (23.7–28.2)

10-12

36.4 (32.3–40.9)

ULBD

<0.001

SHBD

6.52 (3.85–11.01)

p < 0.001

2.64 (1.76–3.96)

p < 0.001

1.91 (1.10–3.31)

p < 0.001

SLBD

1.64 (1.10–2.45)

UHBD

11.09 (5.97–20.58)

p < 0.001

ULBD

5.52 (3.32–9.18)

p < 0.001

SHBD

2.72 (1.45–5.11)

p < 0.001

SLBD

2.71 (1.69–4.38)

p < 0.001

Positive

p < 0.001

UHBD
Yes

ULBD

21.6 (19.5–23.7)

1

SHBD
Education

SLBD

0.15

1.39 (0.95–2.01)

ns

ULBD

1.44 (1.01–2.05)

p<0.01

SHBD

1.17 (0.71–1.92)

ns

SLBD

1.23 (0.88–1.71)

ns

UHBD
No

24.3 (22.0–26.6)

UHBD
High

ULBD

22.4 (20.5–24.4)

1

SHBD
SLBD
0.64 (0.24–1.66)

UHBD

Fournet, F., et
al.

2016

Burkina Faso

Ouagadougou

Cross-sectional

Population

Seroprevalence study
to analyse flavivirus
prevalence relative to
the socioeconomic,
demographic, health
May-Sept 2004
and environmental
data concerning
children, their family
and household and the
district.

Socioeconomic level

Medium

26.5 (23.2–29.8)

Low

18.2 (14.8–21.5)

ULBD

0.003

SHBD
Children from
Ouagadougou
districts with
different types
and degrees of
urbanization

SLBD
3015

0-12

Clinical data

DENV IgM+,
DENV IgG+

Prevalence

IgG (22.7%)

Flavivirus IgM
and IgG ELISA

Prevalence

22.7% (96 CI
22.4-26.7)

Past (IgG)
Flavivirus
seroprevalence

Chi2

Logistic
regression
analysis

ns

1.65 (0.49–5.53)

ns

1.83 (0.99–3.39)

p<0.05

2.01 (1.21–3.33)

p<0.01

0.47 (0.19–1.18)

ns

ULBD

1.03 (0.39–4.31)

ns

SHBD

1.20 (0.65–2.21)

ns

SLBD

1.50 (0.91–2.47)

UHBD

OR

ns

UHBD
Tap

ULBD

22.2 (19.0–25.5)

1

SHBD
SLBD
0.55 (0.25–1.22)

UHBD
Water supply

Pump

21.9 (20.2–23.7)

Well

28.9 (23.6–34.2)

7.39 (0.93–58.07)

ULBD

0.03

0.76 (0.45–1.32)

SHBD

0.84 (0.57–1.24)

SLBD

ns
p<0.05
ns
ns

0.84 (0.32–2.23)

ns

ULBD

10.27 (1.28–82.41)

p< 0.01

SHBD

1.34 (0.31–5.75)

ns

SLBD

1.22 (0.52–2.83)

UHBD

ns

UHBD
Improper

ULBD

24.1 (22.0–26.3)

1

SHBD
Waste management

SLBD

0.05

Adequate

21.2 (19.1–23.2)

Good

24.4 (20.1–23.6)

UHBD

1.56 (1.05–2.34)

ULBD

1.17 (0.82–1.66)

ns

SHBD

1.92 (1.11–3.34)

p<0.01

SLBD

0.90 (0.62–1.30)

p<0.05

ns

UHBD
ULBD

1

SHBD
Housing appearance

SLBD

0.12

UHBD
Not good

UHBD
Strata

Buidling density

Region

Hortion, J., et
al.

2019

Kenya

Western and
coastal

Cohort

Individual

This seroprevalence
study aimed to
investigate the
frequency of
alphavirus and
flavivirus incident
infections in two
regions in Kenya and
identify potential risk
factors

Area type
Dec 2014-Dec
2015

Acutely ill children
presenting at one
of four healthcare
centres

ELISA IgG
CHIKV and IgG
DENV

1604

Prevalence

21.9 (21.7–27.2)

Number of other children
living in the hours (in
addition to 1)

ns

ULBD

2.16 (1.53–3.04)

p<0.001

SHBD

0.56 (0.45–1.45)

ns

SLBD

1.02 (0.68–1.53)

ns

20.2 (17.6–22.9)

ULBD

25.0 (22.1–28.0)

SHBD

16.8 (13.6–19.7)

SLBD

27.8 (24.4–30.9)

High

18.9 (16.8–20.8)

Low

26.3 (24.1–28.5)

Western

2.3% (11/486)

Coastal

4.4% (49/1,118)

Urban

3.6% (29/817)

Rural

3.9% (31/787)

<0.001

<0.001

p=0.044
Chi2 or Fisher
exact test
p=0.70

0

3.7% (60/1604)

0.79 (0.49–1.29)

OR

1-2
3-5
6+

Age

Young school children

19.2 (5.7-65.1)

Older school children
<14
15-29
Age group

Jing, Q et al

2019

China

Guangzhou

Cross-sectional

Individual

Seroprevalence study
to understand the
prevalence of DENV in
communities with no
reported cases in
Guangzhou, China and
assess risk factors that
may be associated
with increased
seropositivity.

2015

850 participants
from 7 selected
communities in
Guangzhou with
no reported
dengue cases
before 2014

850

F: 457 M: 393

between 1-84
yo

Laboratory
data

Gender
IgG ELISA

Prevalence

6.59%

Level of education

Housing Type

1.54 (0.54-4.42)

0.03

2.53 (1.08-5.96)

0.09

2.07 (0.89-4.83)

>=60

(14) 10.69%

0.01

2.84 (1.23-6.58)

Female

Ecuador

Machala

Cross-sectional

Household level

The authors conducted
a household-level
study to identify KAP
and social-ecological
risk factors associated
with acute or recent
DENV infections in the
city of Machala,
Ecuador.

2014-2015

Individuals with
DENV infections
from sentinel
clinics - as well as
219 households
members of the
in total : 44
same household
index HHs, 175
and four
associate HHs
neighboruing
households
located within
200m

NS1 RDT, RTPCR and IgM
ELISA

DENV

Prevalence

1.53 (0.20-11.87)
2.11 (0.26-17.35)

Multistory without elevator

Secondary or higher
If employed, make more than
minimum wage
If employed, employment is
stable
No. of people per HH - mean (SD)
No. of bedrooms - mean (SD)
No. of people per bedroom mean (SD)
Rented property
Adjacent abandoned property
Screens on windows/doors
Piped water inside house

Water supply

Standing water
Water containers covered
1-13

Age group

Khan, J., et al.

2018

Pakistan

Swat

Cross-sectional

DENV patient samples

2013-2015

59765

Clinical data
from hospital

RT-PCR

Incidence

Level of education

Monthly income in
Pakistani rupees

OR

0.48

(1) 2.94

1
0.46

2.21 (0.29-16.57)

0.45

3.08 (0.39-24.25)

0.04
0.03
0.87
0.82
0.94
0.1
Chi2

2.18 (1.32) vs 2.02 (1.32)
19.4% (27/139) vs 13.8%
(11/80)
37.0% (51/138) vs 22.8%
(18/79)
10.8% (15/139) vs 8.75%
(7/80)
70.5% (98/139) vs 85.0%
(68/80)vs 44.3%
42.8% (59/138)

14-30

52.5% (2727/5190)

31-60

34.5% (1792/5190)
3.8% (197/5190)

Primary

38.4% (2115/5513)

Middle

29.5% (1627/5513)
20.7% (1139/5513)

Higher

11.5% (632/5513)

5000-10000

63.0% (3475/5513)

10001-20000

21.2% (3475/5513)

20001-35000

10.4% (574/5513)

Above 35000

5.4% (296/5513)

0.67

OR

0.39
0.29
0.03

2.89 (1.13-7.34)

p=0.03

0.15 (0.05-0.47)

p=0.001

0.75
0.02
0.82

(35/79)
42.4% (59/139) vs 30.0%
(24/80)
9.1% (474/5190)

Bachelor

Positive

1

(41) 6.28%
(14) 8.54%

Above 60

p = 0.02

1.52 (0.88-2.62)

46.3 (12.8) vs 50.3 (14.7)
19.4% (27/139) vs 32.5%
(36/80)
59.1% (81/137) vs 60.3%
(47/78)
44.2% (50/113) vs 46.2%
(24/52)
72.4% (89/123) vs 72.9%
(43/59)
4.73 (1.91) vs 4.29 (1.86)
2.55 (1.04) vs 2.49 (1.10)

1.04 (1.01-1.07)

1
DENV
seropositivity

0.68

(9) 7.5%

(1) 3.03%

Level of education

Household characteristics

0.14
t-test

(31) 7.89%
(46) 6.61%

Highschool

Multistory with elevator

Female

Household with
DENV

(25) 5.47%

Male
Middle school and lower

Sex

Employment

Clinical data

(6) 4.58%

College degree and higher

Single story

2017

1
0.42

(13) 8.72%
(13) 7.22%

Age - mean (SD)

Kenneson, A.,
et al.

(10) 3.86%

30-34
45-59

0.07

<0.001

Chi2

<0.001

<0.001

Age (in years)
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Kikuti, M., et
al.

2015

Brazil

Salvador

Cross-sectional

Individual and
population

Conducted enhanced,
community-based
surveillance in the
only public emergency
unit in a slum in
Salvador, Brazil to
identify acute febrile
illness (AFI)
patients with
laboratory evidence of
dengue infection.

Self reported race

2009-2010

2962

>5

DENV IgM+.
RT_PCR

Clinical data

Incidence

Black

49% (278/569)

Mixed

39% (224/569)

White

9% (50/569)

Other

3% (17/569)

Illiterate partcipants
aged ≥ 15 years
Households with per
capita
monthly income
Households
with ≤
inadequate sewer
Households without publc
water supply
Households
without

BMJ Global Health

OR

1% (5/352)

garbage collection
Sex

Age
Community
based cohort

Kuan, G., et al.

2016

Nicaragua

Children aged
2–14 years
Mar/Apr 2015 enrolled in the
2016
Pediatric Dengue
Cohort Study

Individual

Two studies were
conducted to analyse
the seroprevalence of
CHIKV after the first
chikungunya epidemic
in a community-based
cohort of children ages
2-14 years and a crosssectional survey of
persons over 15 years
old in the same are of
Managua, Nicaragua.

Managua

Cross-sectional

Individual

3362

6.1% (95%CI
5.3-6.9)

2-14yrs

Socioeconomic status a

Daily hours without
water

ELISA

Prevalence

Sex

individuals aged
15 years recruited
door-to-door
specifically for
this study.

848

13.1% (95%CI
10.9-15.5)

>15

6.4 (5.3, 7.7)
5.7 (4.6, 6.9)

2-4

4.8 (3.4, 6.5)

5-9

4.2 (3.2, 5.4)

10-14

8.9 (7.4, 10.7)

Not poor

Socioeconomic status a

Daily hours without
water
Per additional person in
the household
Sex

11.80
(10.41–13.18)

IgG

Liu, J., et al.

2018

China

Guangzhou

This cross-sectional
study explored the
sero-prevalence of
dengue virus infection
in Guangzhou

Cross-sectional

2013-2015

Level of education

Clinical data

Prevalence
Sex

Age

3.98
(3.14–4.82)

IgM

Educational status

Marital Status

Luo, D., et al.

1995

China

Southern
Henan Province

Case-control

Population

A population-based
case-control study in
Southern Henan
Province, central
China, which examines
children with Japanese
Active case finding
encephalitis (JE) and
in hospitals in Gusi
Jun-Sept 1991
compares them with
County, Henan,
neighborhood controls
China
matched by age and
sex in terms of several
social and
environmental
variables.

>6months - 10
years

JEV diagnosed
clinically and
confirmed by
laboratory
testing

Prevalence

2013

Thailand

Southern
Thailand

Cross-sectional

2008

4.8 (3.8, 6.1)

Parental education

1

1
1.33 (1.11-1.58)b
1

Prevalence

b

p<0.05

Positive

Positive

1-7

6.2 (4.2, 8.7)

1.07 (0.85, 1.34)

ns

1.07 (0.85-1.34)

ns

>8

7.7 (5.4, 10.5)

1.33 (1.06-1.65)

p<0.05

1.31 (1.05-1.63)b

p<0.05

Positive

0.97 (0.95-0.99)

p<0.05

0.96 (0.95-0.98)c

p<0.05

Negative

Male

14.1 (9.9, 19.2)

Female

12.7 (10.2, 15.6)

15-29

13.8 (9,7, 18.8)

30-44

10.3 (6.7, 15.2)

45-59

14.4 (9.8, 19.9)

>60

14.1 (9.5, 19.8)

Not poor

11.1 (7.9, 14.9)

Poor

14.4 (11.5, 17.8)

1.11 (0.82-1.49)

ns

1.05 (0.78-1.41)

ns

0.70 (0.47-1.04)

1

PR

ns

1

1
0.74 (0.50-1.10)

CHIKV
seropositivity

1
ns

1.04 (0.72-1.50)

ns

0.98 (0.68-1.41)

ns

1.02 (0.70-1.48)

ns

0.93 (0.64-1.36)

ns

1
1.29 (0.97-1.72)

1
ns

1

1.11 (0.82-1.51)

Positive
ns

0

12.1 (9.7, 14.9)

1-7

17.8 (9.8, 28.5)

1.47 (0.95-2.26)

ns

1.48 (0.96-2.28)

>8

15.2 (9.7, 22.3)

1.25 (0.88-1.78)

ns

1.25 (0.88-1.78)

ns

-

-

0.97 (0.95-0.99)

p<0.05

0.96 (0.95-0.98)

p<0.05

Male

12.96 (10.57–15.34)

Female

11.13 (9.43–12.83)
5.08 (3.00–7.16)

41-65

7.07 (5.14 –9.00)

>65

30.34 (26.51 –34.17)

Illiterate

14.47 (8.94–19.99)

Primary

16.25 (12.78–19.72)

1

Positive
ns

Negative

1

0.212

0.84 (0.64–1.10)

1.68 (0.44–2.92)

19-40

1
3.13 (1.32–7.40)

0.000

Positive

4.45 (1.99 –9.92)

Positive

25.45 (11.80 –54.89)

Positive

1
Past CHIKV
infection

1.15 (0.69–1.91)

0.000

Junior high school

13.85 (10.56–17.14)

Senior high school

8.25 (5.82–10.68)

0.95 (0.56–1.60)
0.53 (0.31–0.92)

Negative

Diploma and higher

8.1 (4.67–11.52)

0.52 (0.28–0.98)

Negative

2.62 (1.26–3.98)

Married

13.94 (12.03–15.84)

Widowed

29.75 (21.49–38.02)

Divorced

16.67 (5.84–39.22)

1
6.01 (3.46–10.47)

0.000

OR

1.14 (0.72–1.82)

<19

4.33 (2.36–6.30)

1

19-40

3.23 (1.56–4.91)
4.86 (3.24 –6.48)

>65

3.23 (1.76 –4.70)

Illerate

3.77 (0.78–6.77)

Positive

-

None mentioned

1

0.575

0.73 (0.36 –1.51)

0.399

?
0.74 (0.38 –1.44)
1
Recent CHIKV
infection

Primary

4.12 (2.25–5.99)

Junior high school

3.52 (1.76–5.28)

Senior high school

6.04 (3.94–8.14)

1.64 (0.67–4.01)

Diploma and higher

3.24 (1.02–5.46)

0.85 (0.29–2.51)

Single

3.56 (1.98–5.13)

1

Married

Positive

7.43 (1.93–28.61)

3.66 (2.33–5.00)
4.16 (3.08–5.24)

41-65

Positive

15.73 (8.14–30.39)
Logistic
regression

Chi2

Male
Female

1.1 (0.43–2.81)

0.081

4.42 (3.28–5.55)

0.93 (0.35–2.44)

1.3 (0.76–2.20)

0.340

Widowed

1.65 (0.45–5.83)

0.46 (0.10–1.98)

Divorced

5.56 (0.99–25.76)

1.59 (0.20–12.61)
1

0.66 (0.26-1.64)

Acute JEV
infection

6-8
≥9

IgG (HI)

b

1

≤5

61.90%

Occupation
Clinical data

ns

1

1.42 (1.21-1.69)

Logistic
regression for
matched casecontrol study

1

0.619

0.49 (0.16-1.48)

Sex

0.96 (0.36-2.54)

1
p=0.006 *

0.55 (0.14-2.03)

0.09 (0.009-0.76)

0.26 (0.26-2.51)

1

1

General

0.71 (0.28-1.80)

37-45

p=0.072*

0.34 (0.10-1.15)

0.85 (0.29-2.47)

Vaccination
p=0.163 *

p=0.26*

0.45 (0.12-1.72 )

55.1% (65/118)
63.6% (82/129)

0.003

64.1% (84/131)

59-91

64.3% (83/129)

Rubber farmer

64.6% (256/396)

Other

p=0.235 *

0.37 (0.09-1.57)

1

Poor

None

Level of education

p=0.038 *

0.25 (0.06-1.02)
OR

Good

>18

p<0.05

1

a

Quality of house

507

ns

1.85 (1.50-2.29)b

6.9 (5.9, 8.1)

46-58

Nakkhara, P.,
et al.

0.88 (0.69-1.11)

1

> 100%
IgG (HI)

1.13 (0.97-1.33)b

ns
p<0.05

1

PR

50-99%

50 cases, 100
controls

ns

0.87 (0.68-1.10)
1.86 (1.50-2.30)

1.13 (0.96-1.32)

CHIKV
seropositivity

5.8 (4.9, 6.8)

18-36

Residents aged 18
years or more
from three villages

0.98 (0.92-1.04)
1.02 (1.00-1.04)

< 50%
Income

Age

Estiamtion of whether
symptomatic and
asymptomatic
chikingunya cases
share the same risk
factors

OR
OR

1.02 (1.01-1.04)

1.02 (1.01-1.03)

0

Single
Marital Status

2085

1.00 (0.99-1.01)

Poor

<19
Age

34 communities;
All samples were
selected from a
200,000-sample
database holding
serum
collected from
community
residents living in
Liwan and Yuexiu
districts of
Guangzhou
between
September 2013
and August 2015,
and 17 to 28
individuals of each
age group were
chosen per
month.

1.13 (1.08-1.18)
1.04 (1.03-1.05)

OR

Per additional person in
the household

Age

Jun-15

Male
Female

1.07 (1.05-0.90)

OR
OR

<0.001

46.0% (23/50)

RR

57.4% (35/61)

None

66.0% (31/47)

Early primary school

67.0% (144/215)

Primary school

56.9% (70/123)

High school

58.2% (57/98)

Diploma or higher

52.9% (12/24)

0.047

Male

-

Female
Residential area

Suburb

-

Village
No formal
Education

DENV NS1
ELISA

8.80%

-

Primary
DENV NS1
seropositivity

Chi2

Secondary
Tertiary

Nasir, I. A., et
al.

2017

Nigeria

Abuja

Cross-sectional

Individual

A hospital-based crosssectional study
investigated the
prevalence of Dengue
virus non-structural
protein-1 (NS1)
antigenaemia, antiMay-Aug 2016
Dengue virus IgG and
their associated risk
factors among febrile
patients attending the
University of Abuja
Teaching Hospital
(UATH), Nigeria.

Civil servant

Occupation
Patients with
febrile illesses
seeking medical
assistance at
hospital

171

Prevalence
Sex

Residential area

Level of education

DENV IgG
ELISA

43.30%

0 (0.0)
4 (12.5)
1 (4.3)

Other

2 (4.2)

M

28 (38.9%)

F

46 (46.5)

Suburb

64 (41.8)

Village

10 (55.6)

No formal

29 (76.3)

Primary

12 (38.7)

Secondary
Tertiary

Occupation

Age

Obaidat, M. M.
and A. A. Roess

2018

Jordan

Cross-sectional

Individual

Seroprevalence study
to understand the
prevalence of DENV in
Jordan and assess risk
factors that may be
assoicated with
increased
seropositivity.

Healthy relatives
of patients at
governmental
human health
centres at 11
governorates

DENV 1-4 IgG
antibodies
SERION
enzyme-linked
immunosorbent
assay classic
dengue virus
IgG

892

Sex

Prevalence

Residential area

24.6% (95% CI
21.8-27.5)

Education

8 (15.1%)

Farmer
Housewife
Unemployed

16 (44.4)

0.166

0.406

0.3896

<0.0001
DENV IgG
seropositivity

Chi2

17 (25.8)

Civil servant

10 (20.8)

Farmer

10 (66.7)

Housewife

14 (50.0)

Unemployed

10 (43.5)

Other

30 (52.6)

0.0034

<20

17.4

20-39

21.1

1.27

p= 0.40

1.22 (0.69-2.15)

1.23 (0.70-2.17)

27

1.75

p= 0.07

1.62 (0.92 - 2.85)

1.64 (0.93-2.90)

36.7

2.75

1

p= 0.00

2.29 (1.19 - 4.43)

2.34 (1.21-4.54)

24.2

1

-

1

1

24.9

1.04

p= 0.80

0.99 (0.71 - 1.37)

0.80 (0.56-1.15)

Rural

20.51

Urban

25.16

DENV
seropositivity

1

-

1

1

0.07

p= 0.04

0.84 (0.57 - 1.24)

0.83 (0.56-1.22)

0.66

p= 0.11

1.25 (0.87 - 1.79)

1.22 (0.85-1.76)

1.51 (0.74–3.10)

p=0.26

1.19
18.35

M

11

Age group
Countrywide study of
the seroprevalence,
Nov 2015- May
risk factors and spatial
2016
distribution of West
Nile virus in Jordan.

Health relatives of
patients at
governmental
human health
centres at 11
governorates

anti-WNV IgG
using an ELISA
kit

Clinical data,
health centres

Prevalence

8.61% (95% CI
6.8-10.8)
Level of education

Any education

IgG (ELISA and
ELISPOT-MNT)

Prevalence

12.5% (95% CI
8.7–16.3)

p= 0.05
p= 0.055

7.1

1
1.03 (1.10-1.04)

p<0.001

15.4

4.09 (0.81-20.54)

p=0.09

4.3

1

9.5

≥50

12.6

No Education

15.6

2.37 (1.18-4.78)
3.23 (1.60-6.51)
WNV
seropositivity

OR

3.33 (1.60-6.93)
1.35 (0.61-2.99)

p=0.46

0.88 (0.31-2.48, )

p=0.81

5.3

1

No education

15.6

2.96 (1.79-4.88)

≤US$750

5.9

p=0.00

1

10.2

2.0 (1.11-3.85)

5.2

p=0.02

1

M

12.3 (8.0–16.5)

1

F

12.6 (7.9–17.4)

1.03 (0.65–1.64)

15-29

8.7 (4.1–13.2)

1

13.3 (9.3–17.4)

1.62 (0.84–3.12)

30-49
50-64

23.9 (9.4–38.3)

No primary

25.8 (16.4–35.2)

Level of education

Incomplete primary

6.5 (3.8–9.2)

Complete primary + secondary

9.2 (4.5–13.8)

1

Lowest

18.4 (11.2–25.7)

1.87 (0.82–4.25)

2nd

11.6 (4.0–19.2)

1.08 (0.41–2.89)

Sex

p=0.00

7
4.6

Age group

Wealth Quintiles

p=0.02

p=0.00

School
College
University degree

>US$750
Sex

1.4
1.62 (0.99-2.66)

F

Any education
Household income

p= 0.34
p= 0.08

6-15

30-49

801

p= 0.29

0.84
1.33

15-29

Age (cont.)

Cross-sectional

p= 0.28

29.6
22.8

Practices agriculture

Jordan

1
1.3

No
Yes

Has garden

2019

1

F
M

Municipal water

Obaidat, M.
M., et al.

1

60-80

Rainwater collection
cisterns
Filtered water

Sex

-

40-59

p=0.89

p=0.06

3.3 (1.22–8.9)

3.06 (0.99–9.52)

3.44 (1.47–8.06)
OR

0.69 (0.34–1.4)

p< .01

p=0.04

p=0.05

1.20 (0.43–3.38)

p=0.73

0.54 (0.22–1.35)

p=0.19

0.50 (0.20–1.26)

p=0.14

0.46 (0.16–1.34)

p=0.16

Middle

9.4 (4.9–14.0)

0.86 (0.36–2.06)

0.44 (0.16–1.22)

p=0.11

4th

11.5 (6.3–16.7)

1.07 (0.48–2.41)

0.72 (0.24–2.15)

p=0.56

Highest

10.8 (4.2–17.4)

1

5.4 (2.4–8.5)

1

F

3.7 (2.2–5.3)

0.67 (0.40–1.15)

15-29

3.3 (1.6–5.1)

1

M

p=0.15

2.7–6.3)
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Age

Ochieng, C., et
al.

2015

Kenya

Cross-sectional

Individual

Seroprevalence study
to understand the
prevalence of DENV,
CHIKC and RVFC in
Kenya and associated
risk factors

2007

HIV-negative
blood specimens
from the 2007
Kenya AIDS
Indicator Survey

30-49
50-64

1091

15-64

Clinical/laborat
ory

No primary
IgG ELISA

Prevalence

4.5% (95% CI
2.7–6.3)

Education level

Wealth Quintiles

Incomplete primary

Age group

Prevalence

1% (95% CI
0.2–1.7)

Education level

Wealth Quintiles

Sex

Omatola, C.A.
et al

2020

Nigeria

Guinea
Savannah

Cross-sectional

Individual

Assess seroprevalence
of DENV in Guinea
Savannah and
highlighting associated
risk factors

2019

Visiting
outpatients from
the four hospitals
in Anyigba

Level of education
200

39% females,
61% males

Laboratory
data

IgG
immunoassay

Prevalence

1

2nd

4.4 (0.0–8.9)

2.87 (0.61–13.42)

Middle

Age

Omatola, C.A.
et al

2020

Nigeria

Kogi state

Cross-sectional

individual

To determine
seroprevalence of
active and past CHIKV
infection among
febrile patients who
test negative for
malaria and typhoid
fever and determine
assoicated risk factors.

p=0.02
p=0.15

30-49

0.4 (0.0–1.1)
1.6 (0.2–3.1)

Febrile
participants at five
hospitals in
Anyigba who test
negative for
typhoid and
malaria

Laboratory
data

243

IgG and IgM
detection kit

Prevalence

34.20%

Level of education

0.4 (0.0–0.9)

1

Lowest

0.7 (0.0–1.9)

1.87 (0.20–17.13)

2nd

1.3 (0.0–3.1)

3.37 (0.40–28.07)

Middle

0.9 (0.0–2.3)

2.41 (0.31–18.96)

4th

2.3 (0.0–5.5)

5.98 (0.77–46.60)

0.4 (0.0–0.9)

1

6 (21.4%)
12 (15.6%)

30-34

15 (24.6%)

45-59

7 (35.0%)

60-74

3 (25.0%)

>74

0

None

13 (27.1%)

Primary

6 (19.4%)

5 (17.9%)

Sex

13 (16.3%)

>=2

30 (25.0%)

Male

45 (40.9%)

Female

38 (28.6%)

5-14

2 (5.4%)

15-29

17 (22.7%)

30-34

41 (49.4%)

45-59

11 (42.3%)

Pereira, Y., et
al

2015

Paraguay

Paraguayan
Chaco

Cross-sectional

Individual

Study to establish the
seroprevalence of
infection by the
dengue virus in a
district of the
Paraguayan Chaco

2014

Inhabitants of
three villages

Household
sampling
confirmed by
laboratory
testing

418

3 (50.0%)

None

13 (32.5%)
7 (21.9%)

Secondary

30 (36.6%)

Tertiary

33 (37.1%)

Prevalence

24.2% (95% CI
20.2% to
28.6%)

Occupation

Monthly income

15 (38.5%)

Business

26 (44.1%)

Student

17 (18.3%)

Housing type

Water service for
consumption
Sex

Age group

Pessanha,
J.E.M., et al

2010

Brazil

Belo
Horizonte

Cross-sectional

Individual

All residents aged
over 1 year in the
threee Belo
June 2006 and
Horizonte districts
March 2007
(Venda Nova, DS
Leste and DS
Centro-Sul)

Family income
Serology to
different DENV
serotypes (type
and lab test not
specified)

Questionnaire
and blood
samples

709

Prevalence

11.9% (96% CI
9.7% to 14.6%)

Changed city

Sex

2010

Socioeconomic status
53.8%(2010) to
64.6%(2012)

13% (24/185)

41-60

34.5% (38/110)

Complete secondary

20.4% (29/142)

Tertiary / university

41.2% (10/53)

Housewife

18.1% (28/155)

Merchant

29.5% (21/71)

2018

Colombia

Medellin

Longitudinal
serosurvey

Population and
individual

Ethnicity

2010-2012

School children

4385

5-19yrs

IgG (ELISA and
ELISPOT-MNT)

Schoolchildren

Incidence

2011

Piedrahita, L.
D., et al.

Age

Socioeconomic status

Gender

9.3% (4/43)
31.4% (11/35)

Public official

22.6% (7/31)

Domestic worker

15.4% (3/13

Unemployed

42.9% (3/7)

Less than minimum wage

24.1% (28/116)

More than the minimum wage

25.3% (56/221)

2012
Colombia

Individual

2014

42.4% (14/33)

No

22.6% (87/385)
0

Wood

11.5% (6/52)

Wall/brick

26.2% (95/363)

Tap water

23.3% (83/373)

Bottled water

27.7% (13/47)

Water well

33.3% (5/15)

Female

11.24% (48/427)

Male

12.77% (36/284)

<15 or >60 years

8.81% (20/227)

F: 382 M: 166

>18 yo

Laboratory
data

IgM or IgG
ELISA

Prevalence

p = 0.002

Positive

0.009

<0.001

0.366

0.003

DENV
seropositivity

0.736

0.008

0.099

0.332

1
1.14 (0.70-1.85)

1.58 (0.93-2.69)

19.90% (54/417)

1

11.60% (75/632)

0.80 (0.46-1.38)

8.14% (14/172)

Average

12.10% (34/281)

High

14.70% (29/197)

0.58

1

13.28% (64/482)

> 2 * minimum wage
Up to 2 * minimum wage

DENV
seropositivity

OR

0.09

0.39

1
1.56 (0.81-2.99)
1.95 (0.99-3.82)

11.90% (7/59)

1.52 (0.58-3.97)

Apartment

5.30% (5/77)

1

House/shack

12.80% (79/615)

2.63 (1.03-8.53)

Yes

11.69% (9/77)

1

No

11.87% (75/632)

1.02 (0.47-2.28)

52.9% (459/867)

1

54.6% (503/921)

1.03 (0.95-1.12)

Afro-descent

45.6% (41/90)

1

Mestizo

54.2% (921/1,698)

1.19 (0.95-1.50)

0.19
0.05
0.39

0.02

0.96
1
1.03 (0.84-1.25)

5-9

34.9% (199/571)

1

10-14

61.6% (594/965)

2.99 (2.41-3.71)

p < 0.05

2.96 (2.38-3.68)

15-19

67.1% (169/252)

3.80 (2.78-5.21)

Low

58.2% (592/1,017

Middle

42.3% (52/123)

p < 0.05

3.71 (2.70-5.09)

p < 0.05

0.70 (0.57-0.86)

p=0.001

0.53 (0.36-0.77)

p < 0.05

0.59 (0.39-0.87)

p=0.009

1
1.04 (0.96-1.12)

63.1% (41/65)

Mestizo

58.8% (1,058/1,800)

1
0.93 (0.77-1.13)

5-9

45.4% (181/399)

10-14

60.2% (660/1,097)

15-19

67.1% (264/392)

Low

60% (682/1,137)

DENV IgG
seropositivity

1

1

Middle

56.5% (368/651)

0.87 (0.72-1.6)

0.86 (0.71-1.05)

p=0.150

High

54.6% (53/97)

0.80 (0.53-1.22)

0.91 (0.59-1.39)

p=0.663

M

59.9% (200/334)

1

F

68.8% (258/375

1.15 (1.03-1.28)

1.38 (1.10-1.89)

p=0.043

OR

1

1

1.90 (1.51-2.30)

p < 0.05

2.60 (1.95-3.47)

p < 0.05

1
0.90 (0.64-1.26)

50% (94/188)

1

Age

10-14

70.5% (292/414)

2.40 (1.68-3.41)

15-19

64.6% (72/107)

2.06 (1.25-3.40)

Low

61.2% (210/343)

1

Socioeconomic status

Middle

68% (247/363)

1.37 (1.0-1.85)

p < 0.05

High

0

2.13 (1.32-3.46)

0.002

Socioeconomic strata
(higher number = more
economic capacity)

<0.001

1

71.4% (10/14)

53.80%

p<0.001

0.67 (0.57-0.84)

57.2% (510/891)
59.6% (594/997)

Afro-descent

p=0.77

1

1

49.1% (318/648)

Male
Feamle

>45 yo

(170) 57.6%

<45 yo

(125) 42.4%

Female

(208) 73.3%

Male

(87) 52.4%

None

(107) 53.8%
(62) 68.9%

158-315 USD

(95) 50.3%

316-471 USD

(16) 39.0%

472-630 USD

(9) 60.0%

631-725 USD

(2) 66.7%

726-906 USD
548

None mentioned

p<0.001

64.5% (448/695)

Monthy income

2019

OR

21% (17/81)

Yes

Plastic/mud

<157 USD

Rueda, J.C. et
al

Logistic
regression

5-9

Sex

548 suspected
CHIKV patients
from the
COPCORD cohort

Positive

CHIKV
seropositivity

Mestizo

Age group

Describe the
demographic and
clinical characteristics
of CHIKV cases

p = 0.43

Afro-descent

Ethnicity

Cross-section
nested in
community
cohort

Chi-squared

39.7% (25/63)

Student
University professional

Male

Positive

1

44% (33/71)
33.3% (6/18)
27.3% (56/205)

High
Sex

This longitudinal
serological survey and
spatial analysis study
estimated dengue
virus (DENV)
transmission in
schoolchildren (aged
5–19 years) in
Medellin from 2010 to
2012.

1.7 (1.014-2.955)

p < 0.001

11.9% (5/42)

20-40

Illiterate
Complete primary

Female
Ethnicity

Age group

p = 0.14

p = 0.044

19 (20.4)

16.7% (1/6)

Very high
Type of housing

None.

p = 0.12

7 (43.8%)

<10

Low
Health vulnerability index

None

p=0.09

6 (27.3%)

31.7% (45/142)
20.3% (56/276)

15 to 60 years
Study to determine
dengue
seroprevalence for to
different viral
serotypes in three
districts in Belo
Horizonte, Brazil
Belo Horizonte

p = 0.46
Chi-square

51 (45.5%)

Male
Female

Has no income
Live alone

p = 0.45

25 (48.1%)

Civil servant

Labourer
DENV IgG
ELISA

p=0.47

9 (56.3%)

75-80

Primary

>=60

p=0.1

p = 0.66

0
3 (23.1%)
14 (15.7%)

1

10-19
Age group

Level of education

p=0.02

p=0.09

26 (28.3%)

Single

Single

p=0.94

3.57 (0.84–15.21)

12 (14.5%)

Widowed/Separated

Divorced

p=0.85

12.09 (1.46–99.86)

7 (24.1%)

19 (31.7%)

Widowed

Geography

9 (15.3%)

Business

Married
Marital status

15 (24.2%)

Civil servant

Divorced

p=0.61

25 (20.5%)

<15
15-29

Farming
Occupation

4.38 (0.75–25.49)

Highest

18 (23.1%)

p=0.11

1

OR

Complete primary + secondary

Male

p=0.81
p=0.96

1.68 (0.23–12.34)
0.93 (0.12–6.89)

1

3.37 (0.80–14.15)

50-64

p=0.69
p=0.08

0.92 (0.48–1.79)
0.97 (0.31–3.05)

1

11.54 (1.40–95.38)

No primary & incomplete primary

0.83 (0.32–2.11)
2.25 (0.90–5.62)

4.22 (0.72–24.64)
1.18 (0.19–7.22)

1.40 (0.32–6.06)

1.6 (0.0–3.3)
0.1 (0.0–0.4)

60-74

2018

1.77 (0.44–7.11)

2.2 (0.1–4.3)

1.5 (0.3–2.6)

Student

Sex

p=<0.01

1.5 (0.3–2.6)

Male

Married

fomatola

2.7 (0.4–5.1)

p<0.01

15-29

Tertiary

Marital status

p=0.05

Female

Farming
Occupation

1.48 (0.52–4.20)
7.81 (2.25–27.13)

Secondary

20.50%

OR

2.3 (1.1–3.5)
11.1 (5.3–16.9)

Female

Age

1.28 (0.57–2.86)
2.76 (1.22–6.26)
4.69 (2.05–10.72)

DENV
seropositivity

3.4 (0.3–6.4)

Lowest

4th

IgG ELISA

4.2 (1.1–7.4)
8.7 (3.1–14.2)
10.0 (3.5–16.4)

Complete primary + secondary

Highest
Sex

BMJ Global Health

1.90 (1.51-2.40)
2.59 (1.94-3.46)

p<0.001
p<0.001

1
p < 0.05

2.32 (1.62-3.31)

<0.001

p < 0.05

1.97 (1.20-3.24)

0.008

Positive

(3) 42.9%

>906 USD

(1) 25.0%

Stratum 1

t-test

CHIKV
seropositivity

OR

None mentioned

(115) 68.0%

2.35 (1.60-3.44)

<0.001

Positive

Stratum 2

(104) 46.0%

0.58 (0.41-0.82)

0.002

Negative

Stratum 3

(60) 52.6%

Stratum 4

(9) 28.1%

0.31 (0.14-0.69)

0.03

Negative

Stratum 5

(6) 85.7%

-

Mestizo

145 (49.7%)
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Race

Caucasian
Afro-American
Amerindian

Education (not in table-- at least Primary school education
in text only)
No education
Sex

Age group

Sissoko, D., et
al.

2008

Mayotte
(France)

Cross sectional

Individual

Household-based cross
sectional serosurvey to
investigate the
association between
CHIKV seropositivity
and risk factors

2005-2006

Household-based;
complex
multistage cluster
sampling of
population of
Mayotte

Length of education
Clinical data

IgG ELISA

Prevalence

37.2% (95% CI=
33.9-40.5)

Age group

Soghaier, M.
A., et al.

2015

Sudan

Cross-sectional

Indiviudal and
community

The objective of this
study was to identify
socio-demographic
factors associated with
the prevalence of
dengue
serotypes in Kassala
State in the eastern
part of Sudan in 2011.

33.2 (24.2–42.2)
39.3 (27.2–51.5)

25-34

41.7 (29.7–53.7)

35-44

40.2 (29.7–50.8)

45-54

26.9 (15.1–38.8)

>55

36.6 (23.3–49.8)

0-6y

42.1 (32.3–51,9)

Randomly
selected
community
population
through multistage cluster
sampling

Sex

540

Clinical data

IgG ELISA

Prevalence

9.4 % (95 % CI:
7.1–12.3)

Level of education

Water source

Household density

Sex

Age group

Swain, S. et al

2020

India

Odisha

Case-control

individual

Identify the social and
ecological factors
associated with
emerging dengue in
Odisha, India

2017

Confirmed dengue
patients within
one year in six
districts of the
state

387 cases and
380 controls

national vector
borne disease
control
program
(tested through
IgM)

Level of education

ELISA
Ethnicity

34.2 (22.1–46.2)
44.8 (33.5–56.2)

Concrete

30.2 (21.9–38.4)

Adobe and stone

44.2 (31.1–57.4)

Makeshift

65.6 (47.6–83.6)

10.0% (26/281)

8.7% (30/344)

Not piped water

12.8% (6/47)

Piped water

9.1% (40/438)

>3

13.5% (24/178)

<3

7.1% (22/311)

Male

0.525

Female

0.478

<15

0.127

16-25

0.233

26-35

0.222

36-45

0.186

>=46

0.233

illterate

0.147

Primary

0.191

Kandy
2018

Sri Lanka

Case-control

Household level

Feb-Apr 2017

Family size

0.84 (0.38-1.86)

p=0.24

p=0.67

1
1.35 (0.49-3.72)

0.56

p=0.56

1
2.08 (1.06-4.09)

0.034

p=0.034

1
Matched

Matched

1

1

1.2 (0.7-1.9)

0.8 (0.47-1.5)

1.2 (0.8-1.8)

0.9 (0.54-1.5)

2.5 (1.4-4.2)

1.4 (0.76-2.8)

1

1

0.845

1.6 (1.1-2.3)

1.4 (0.9-2.1)

none

logistic analysis

0.098

OR

1

Adjusted for other
variables - not
specified

1

Agriculture

0.194

3.9 (2.1-7.5)

3.8 (1.8-7.9)

p < 0.05

Positive

Business

0.088

3.5 (1.7-7.4)

4.6 (1.9-10.6)

p < 0.05

Positive

0.465

4.6 (2.6-8.1)

0.155

2.7 (1.4-5.2)

0.199

1

4.4 (2.3-8.4)
3.0 (1.4-6.5)

p < 0.05
p < 0.05

Positive
Positive

1

Concrete

0.346

1.9 (1.3-2.9)

1.9 (1.2-3.1)

p < 0.05

Positive

Mixed

17.8]%

1.6 (1.1-2.6)

2.0 (1.1-3.5)

p < 0.05

Positive

Thatched

0.276

2.6 (1.7-4.1)

2.9 (1.7-5.1)

p < 0.05

Positive

0-15

15 (1.50) vs 355 (35.5)

15-35

277 (27.7) vs 422 (42.2)

213 (21.3) vs 66 (6.6)

M

903 (90.30) vs 608 (60.8)

p=0.01

970 (9.70) vs 392 (39.2)
165 (16.5) vs 316 (31.6)

4-6

520 (52.0) vs 504 (50.4)

>7

315 (31.5) vs 180 (18.0)

p=0.04

3 (0.3) vs 4 (0.4)

5-10

20 (2.0) vs 46 (4.6) )

10-20

55 (5.5) vs 258 (25.8)

p=0.02

605 (60.5) vs 472 (47.2)
317 (31.7) vs 220 (22.0)

0-15

18 (1.8) vs 207 (20.7)

15-35

302 (30.2) vs 488 (48.8)

35-55

517 (51.7) vs 230 (23.0)

M

p=0.04

495 (49.5) vs 155 (15.5)

>55

Chi2

p=0.03

162 (16.2) vs 75 (7.5)
883 (88.3) vs 586 (58.6)

F

117 (11.7) vs 414 (41.4)

1-3

247 (24.7) vs 396 (39.6)

4-6

458 (45.8) vs 498 (49.8)

>7

295 (29.5) vs 106 (10.6)

<5

Monthly income

OR

0.155

>55
Sex

DENV
seropositivity

SC/ST

>30

Age

p=0.69

1
0.67

Non SC/ST

23-30
2000 cases,
2000 controls

Colombo

Udayanga, L.,
et al.

1.17 (0.55-2.5)
1.55 (0.74-3.25)

0.24

0.424

1-3

Monthly income

1

p=0.69

0.238

F

Random selection
of 200 households
reporting past
dengue incidence
and 200 nondengue reported
households

p=0.054

p=0.0009

High school or above

<5

Evaluation of
demographic, socioeconomic an dother
assoicated risk factors
affecting the
occurrence of DENV
incidence.

p=0.058

Secondary

35-55

Family size

OR
p=0.035

8.7% (18/206)

8.5% (17/199)
11.1% (16/144)

Formal education

Asbestos

Sex

Adjusted Wald
X2 test

10.1% (29/288)

Female
No formal education

Industry/office

Age (Control, case n(%)

p=0.33

p=0.003

46.7 (36.6–56.9)

<35

Home maker/student

Housing

Positive

35.1 (24.4–45.8)

61.2 (45.9–76.5)
31.6 (23.8–39.4)

Male

p = 0.048

1.43 (1-2.05)
p=0.03

34.3 (24.6–44.1)

Below median threshold
At or over median threshold

Unemployed

Occupation

25.7 (16.4–35.1)
28.6 (19.9–37.3)

Schooled
Unemployed/housewife

3-4

1

-

2-14
15-24

>35

2011

-

33.8 (23.8–43.9)

>5
Asset index

8 (33.3%)

Female

1-2
Household size

29 (70.7%)

40.6 (32.6–48.7)

Employed
Occupation

Construction type

110 (58.5%)

Male

>6y
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p=0.03

p=0.03

0 (0) vs 5 (0.5)

5-10

0 (0) vs 35 (3.5)

10-20

50 (5.0) vs 395 (39.5)

23-30

266 (26.6) vs 275 (27.5)

>30

684 (68.4) vs 290 (29.0)

p=0.008

Power GM, et al. BMJ Global Health 2022; 7:e007735. doi: 10.1136/bmjgh-2021-007735

BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
placed on this supplemental material which has been supplied by the author(s)

Supplemental material

BMJ Global Health

Resumo

Introdução
Os arbovírus possuem notável importância em saúde pública em todo o mundo devido
ao seu potencial de causar grandes surtos e de gerar manifestações clínicas debilitantes
ou possivelmente fatais. Esta revisão sistemática e meta-análise tem como objetivo
avaliar a relação entre indicadores de posição socioeconômica (SEP, sigla em inglês) e
infecção por arboviroses com mosquitos vetores.

Métodos

Realizamos uma busca sistemática nas bases de dados Pubmed, Embase e LILACS para
identificar estudos publicados entre 1980 e 2020 medindo a associação entre
marcadores de SEP e infecção por arboviroses. Incluímos os estudos observacionais,
sem realizar restrições por localização geográfica ou idade. Excluímos estudos da
literatura cinzenta, revisões e ecológicos. Os dados dos estudos foram extraídos,
resumidos e utilizada a meta-análise com efeitos aleatórios para obtenção das
estimativas combinadas de efeito.

Resultados

Identificamos 36 estudos observacionais usando dados referentes a 106.524
participantes do estudo em 23 localizações geográficas que examinaram empiricamente
a relação entre indicadores socioeconômicos e infecções causadas por sete arbovírus
(vírus da Dengue, Chikungunya, Encefalite Japonesa, Febre do Vale do Rift, Sindbis,
Febre do Nilo Ocidental e Zika). Embora os resultados tenham variado, a síntese
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descritiva apontou um maior risco de infecção por arboviroses associado a indicadores
de SEP mais baixos, incluindo menor escolaridade, menor renda, baixa cobertura de
saúde, materiais de habitação precários, abastecimento de água interrompido, estado
civil (casado, solteiro, divorciado ou viúvo), etnias não brancas e status migratório. As
estimativas brutas combinadas indicaram um risco aumentado de infecção por
arboviroses associado à baixa escolaridade (RR = 1,5 IC 95%: 1,3, 1,9); I2=83,1%),
interrupção do abastecimento de água (RR = 1,2; IC 95%: 1,1,1,3; I2 = 0,0%) e ser
casado anteriormente (RR = 1,5 IC 95%: 1,1, 2,1; I2=85,2%).

Conclusão

As evidências dessa revisão sistemática sugerem que pior SEP aumenta o risco de
adquirir infecção por arbovírus. No entanto, houve grande heterogeneidade entre os
estudos. Mais estudos são necessários para definir a relação entre indicadores
específicos de SEP a nível individual, domiciliar e comunitário e a infecção por arbovírus
para informar intervenções direcionadas de saúde pública.

Palavras-chave: posição socioeconômica, equidade em saúde, infecção por arbovírus,
mosquitos vetores, revisão sistemática
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Resumen

Introducción
Los arbovirus son de notable importancia para la salud pública global por su potencial de
causar brotes explosivos además de manifestaciones clínicas debilitantes y potencialmente
letales. Esta revisión sistemática y meta-análisis tiene como objetivo la evaluación de la
relación entre indicadores de posición socioeconómica (PS) e infecciones por arbovirus
transmitidos por mosquitos vectores.

Métodos

Realizamos una búsqueda sistemática en las bases de datos Pubmed, Embase, y LILACS para
identificar estudios publicados entre 1980 y 2020 que median la asociación entre marcadores
de PS e infección arboviral. Incluimos estudios observacionales sin restricciones sobre la
localidad geográfica o edad de los participantes. Excluimos estudios de la literatura gris,
revisiones y estudios ecológicos. Los hallazgos de los estudios fueron extraídos y resumidos y
se realizaron meta-análisis de efectos aleatorios para obtener estimaciones combinadas de
efecto.

Resultados

Identificamos 36 estudios observacionales con datos pertenecientes a 106,524 participantes
de 23 localidades geográficas que examinaron empíricamente la relación entre factores
socioeconómicos e infecciones causadas por siete arbovirus (Dengue, Chikungunya,
Encefalitis Japonesa, Fiebre del Valle de Rift, Sindbis, Fiebre del Nilo Occidental, y el Zika).
Mientras que los resultados fueron variados, la síntesis descriptiva señaló un riesgo mayor de
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infección arboviral asociada con marcadores de PS más bajos, incluyendo menor nivel
educativo, escasez de ingresos, baja cobertura de saneamiento,

materiales de

viviendas de baja calidad, interrupciones del suministro de agua, estado civil (casado, soltero,
divorciado o viudo), grupos étnicos no caucásicos y estatus migratorio. Las estimaciones
agrupadas brutas indicaron un riesgo aumentado de infección arboviral asociado con menor
nivel educativo (RR = 1.5 95% CI: 1.3, 1.9); I2=83.1%), interrupciones del suministro de agua
(RR = 1.2; 95% CI: 1.1,1.3; I2 = 0.0%) y haber estado casado (RR = 1.5 95% CI: 1.1, 2.1;
I2=85.2%).

Conclusión

Esta revisión sistemática señala que el tener una PS inferior aumenta el riesgo de adquirir
infección arboviral, sin embargo hubo una gran heterogeneidad entre los estudios. Más
estudios son necesarios para mejor definir la relación entre indicadores de PS individuales, a
nivel de hogar, y a nivel comunitario y la infección arboviral para mejor diseñar
intervenciones de salud pública dirigidas.
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